<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>Barbiturate</title><meta name="description" content="Barbiturates are a class of sedative-hypnotic drugs derived from barbituric acid, which act as central nervous system depressants by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at GABA_A receptors, leading to sedation, hypnosis, and anticonvulsant properties. First synthesized in 1864 by Adolf von Baeyer, though barbituric acid itself lacks pharmacological activity, the class gained clinical prominence in the early 1900s with the introduction of barbital, revolutionizing..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="keywords" content="barbs"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/Barbiturate"/><meta property="og:title" content="Barbiturate"/><meta property="og:description" content="Barbiturates are a class of sedative-hypnotic drugs derived from barbituric acid, which act as central nervous system depressants by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at GABA_A receptors, leading to sedation, hypnosis, and anticonvulsant properties. First synthesized in 1864 by Adolf von Baeyer, though barbituric acid itself lacks pharmacological activity, the class gained clinical prominence in the early 1900s with the introduction of barbital, revolutionizing..."/><meta property="og:url" content="https://grokipedia.com/page/Barbiturate"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Barbiturate"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:43.867Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Barbiturate"/><meta name="twitter:description" content="Barbiturates are a class of sedative-hypnotic drugs derived from barbituric acid, which act as central nervous system depressants by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at GABA_A receptors, leading to sedation, hypnosis, and anticonvulsant properties. First synthesized in 1864 by Adolf von Baeyer, though barbituric acid itself lacks pharmacological activity, the class gained clinical prominence in the early 1900s with the introduction of barbital, revolutionizing..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="565dfc63251084b67237a4026cf06277-c94f207abcfbcb44-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=565dfc63251084b67237a4026cf06277,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.08365691251904006,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#barbiturate" class="transition-opacity hover:opacity-100 opacity-50">Barbiturate</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#chemical-structure-and-classification" class="transition-opacity hover:opacity-100 opacity-50">Chemical Structure and Classification</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#derivatives-of-barbituric-acid" class="transition-opacity hover:opacity-100 opacity-50">Derivatives of Barbituric Acid</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#duration-based-classification" class="transition-opacity hover:opacity-100 opacity-50">Duration-Based Classification</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#history" class="transition-opacity hover:opacity-100 opacity-50">History</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#discovery-and-synthesis" class="transition-opacity hover:opacity-100 opacity-50">Discovery and Synthesis</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#medical-adoption-and-expansion" class="transition-opacity hover:opacity-100 opacity-50">Medical Adoption and Expansion</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#decline-due-to-safety-concerns" class="transition-opacity hover:opacity-100 opacity-50">Decline Due to Safety Concerns</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pharmacology" class="transition-opacity hover:opacity-100 opacity-50">Pharmacology</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#mechanism-of-action" class="transition-opacity hover:opacity-100 opacity-50">Mechanism of Action</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pharmacokinetics-and-metabolism" class="transition-opacity hover:opacity-100 opacity-50">Pharmacokinetics and Metabolism</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#therapeutic-applications" class="transition-opacity hover:opacity-100 opacity-50">Therapeutic Applications</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#human-medical-uses" class="transition-opacity hover:opacity-100 opacity-50">Human Medical Uses</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#veterinary-and-procedural-uses" class="transition-opacity hover:opacity-100 opacity-50">Veterinary and Procedural Uses</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#risks-and-adverse-effects" class="transition-opacity hover:opacity-100 opacity-50">Risks and Adverse Effects</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#acute-side-effects-and-toxicity" class="transition-opacity hover:opacity-100 opacity-50">Acute Side Effects and Toxicity</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#dependence-tolerance-and-withdrawal" class="transition-opacity hover:opacity-100 opacity-50">Dependence, Tolerance, and Withdrawal</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#overdose-management-and-lethality" class="transition-opacity hover:opacity-100 opacity-50">Overdose Management and Lethality</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#comparative-efficacy-and-safety" class="transition-opacity hover:opacity-100 opacity-50">Comparative Efficacy and Safety</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#barbiturates-versus-benzodiazepines" class="transition-opacity hover:opacity-100 opacity-50">Barbiturates Versus Benzodiazepines</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#reasons-for-therapeutic-replacement" class="transition-opacity hover:opacity-100 opacity-50">Reasons for Therapeutic Replacement</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#controversies-and-societal-debates" class="transition-opacity hover:opacity-100 opacity-50">Controversies and Societal Debates</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#truth-serum-applications-and-limitations" class="transition-opacity hover:opacity-100 opacity-50">Truth Serum Applications and Limitations</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#role-in-euthanasia-assisted-suicide-and-capital-punishment" class="transition-opacity hover:opacity-100 opacity-50">Role in Euthanasia, Assisted Suicide, and Capital Punishment</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#legal-and-regulatory-framework" class="transition-opacity hover:opacity-100 opacity-50">Legal and Regulatory Framework</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#controlled-substance-status" class="transition-opacity hover:opacity-100 opacity-50">Controlled Substance Status</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#patterns-of-non-medical-use" class="transition-opacity hover:opacity-100 opacity-50">Patterns of Non-Medical Use</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#specific-compounds-and-examples" class="transition-opacity hover:opacity-100 opacity-50">Specific Compounds and Examples</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="barbiturate" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Barbiturate<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7"></span>
<span class="mb-4 block break-words text-[1em] leading-7">Barbiturates are a class of sedative-hypnotic drugs derived from barbituric acid, which act as central nervous system depressants by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at GABA_A receptors, leading to sedation, hypnosis, and anticonvulsant properties.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_41abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_61abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> First synthesized in 1864 by Adolf von Baeyer, though barbituric acid itself lacks pharmacological activity, the class gained clinical prominence in the early 1900s with the introduction of barbital, revolutionizing treatment for insomnia, anxiety, epilepsy, and as anesthetics.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Despite their efficacy, barbiturates exhibit a narrow therapeutic index, where the dose for therapeutic effect closely approaches that causing respiratory depression, coma, and death, compounded by rapid tolerance development and high abuse liability that fosters physical dependence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_41qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_61qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> This has led to their replacement in most indications by benzodiazepines and other agents with wider safety margins, restricting modern use primarily to refractory status epilepticus, certain neonatal conditions, and veterinary euthanasia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> Historical overprescription contributed to widespread iatrogenic addiction and overdose epidemics, underscoring the causal link between their pharmacological profile and public health risks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<h2 id="chemical-structure-and-classification" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Chemical Structure and Classification<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="derivatives-of-barbituric-acid" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Derivatives of Barbituric Acid<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">
Barbiturates constitute a class of sedative-hypnotic drugs obtained by modifying barbituric acid, the parent compound chemically known as pyrimidine-2,4,6(1H,3H,5H)-trione, which itself exhibits no central nervous system depressant effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_63abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_83abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> The key structural alteration involves disubstitution at the 5-position of the barbituric acid ring with alkyl, aryl, or other lipophilic groups, such as ethyl and phenyl in phenobarbital (5-ethyl-5-phenylbarbituric acid) or ethyl and 1-methylbutyl in pentobarbital.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> This modification enhances lipid solubility and enables binding to GABA_A receptors, conferring pharmacological activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Synthesis of these derivatives typically proceeds via condensation of diethyl malonate derivativesâ€”alkylated at the alpha positionâ€”with urea or thiourea under basic conditions, followed by cyclization and hydrolysis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_43qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup> More than 2,500 such compounds have been synthesized since the early 20th century, with variations in substituents influencing potency, duration of action, and solubility; for instance, dialkyl substitutions like in barbital (5,5-diethylbarbituric acid) yield longer-acting agents, while aryl-alkyl combinations produce intermediate effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_83qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Further derivatization includes replacement of the 2-position oxygen with sulfur, forming thiobarbiturates such as thiopental (5-ethyl-5-(1-methylbutyl)-2-thiobarbituric acid), which exhibit greater lipophilicity, rapid onset, and ultrashort duration due to redistribution from the brain.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_44abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> Approximately 50 barbiturate derivatives have entered clinical use, including phenobarbital (introduced 1912), pentobarbital, and secobarbital, though many were later restricted due to safety profiles.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_84abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> These structural insights underpin classifications by duration, with short-acting agents favoring branched alkyl chains at C-5 for quicker metabolism.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup></span>
<h3 id="duration-based-classification" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Duration-Based Classification<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Barbiturates are classified based on the duration of their sedative-hypnotic effects, which correlates with their lipid solubility and rate of redistribution from the brain to peripheral tissues, influencing onset, peak action, and termination of effect independent of hepatic metabolism in many cases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_45abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> This system divides them into ultra-short-acting, short-acting, intermediate-acting, and long-acting categories, guiding clinical applications from rapid anesthesia induction to chronic seizure control.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_85abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Ultra-short-acting barbiturates exhibit effects lasting approximately 5 to 30 minutes following intravenous administration, primarily due to rapid redistribution into less vascularized tissues.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_45qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> Examples include thiopental (also known as thiopentone), which has an onset of 10 to 30 seconds and a hypnotic duration of 5 to 10 minutes, and methohexital, with similar pharmacokinetics suited for brief procedures.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_85qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> These agents are almost exclusively reserved for anesthesia induction owing to their fleeting action.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Short-acting barbiturates produce hypnosis for 2 to 6 hours, with oral onset in 15 to 30 minutes and peak effects within 1 to 2 hours.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_46abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> Representative compounds are pentobarbital (Nembutal), featuring a half-life of 15 to 50 hours but shorter hypnotic duration due to redistribution, and secobarbital (Seconal), often used historically for preoperative sedation or short-term insomnia treatment.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_86abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Intermediate-acting barbiturates have durations of 3 to 8 hours, balancing sedation needs for procedures or sleep without excessive hangover effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_46qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> Amobarbital (Amytal) exemplifies this group, with hypnotic effects lasting 4 to 6 hours after oral dosing, while butalbital, typically combined in formulations for tension headaches, shares comparable kinetics.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_86qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Long-acting barbiturates sustain effects for 6 to 12 hours or longer, often extending to 24 hours or more for hypnotic purposes, owing to slower redistribution and reliance on metabolic elimination.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_47abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup> Phenobarbital (Luminal), with a half-life of 37 to 140 hours, is the prototypical agent, employed for epilepsy management due to its prolonged anticonvulsant activity despite accumulation risks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_87abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>






























<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Category</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Approximate Hypnotic Duration</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Key Examples</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Ultra-short-acting</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">5â€“30 minutes</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Thiopental, methohexital</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Short-acting</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2â€“6 hours</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Pentobarbital, secobarbital</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Intermediate-acting</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">3â€“8 hours</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Amobarbital, butalbital</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Long-acting</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">6â€“12+ hours</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Phenobarbital</span></td></tr></tbody></table></div>
<span class="mb-4 block break-words text-[1em] leading-7">This table summarizes typical durations derived from clinical pharmacology data, though individual variability arises from dose, route, and patient factors such as age or liver function.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_48abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_68abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<h2 id="history" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">History<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="discovery-and-synthesis" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Discovery and Synthesis<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"></span>
<span class="mb-4 block break-words text-[1em] leading-7">Barbituric acid, the parent compound of barbiturates, was first synthesized on November 27, 1864, by German chemist Adolf von Baeyer through the condensation of urea and malonic acid.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> The name derives from the fact that Baeyer prepared it on the feast day of Saint Barbara.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup> Although barbituric acid itself exhibited no significant pharmacological activity, its structure provided a foundation for subsequent derivatization efforts aimed at exploring potential therapeutic applications.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_caabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The synthesis process involved reacting urea with diethyl malonate under basic conditions, yielding the cyclic barbituric acid core characterized by two carbonyl groups adjacent to a nitrogen atom in a pyrimidine ring.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> This method was later refined by French chemist Ã‰douard Grimaux in 1879, improving yields and purity for further chemical investigations into uric acid derivatives.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> Early work focused on structural elucidation rather than biological effects, as barbituric acid and initial analogs showed no hypnotic or sedative properties in preliminary tests.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_caqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Breakthrough in pharmacological utility occurred in 1903 when Emil Fischer, a Nobel laureate in chemistry and former collaborator of Baeyer, synthesized 5,5-diethylbarbituric acid (barbital).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> Fischer patented the compound in January 1903, and pharmacologist Joseph von Mering demonstrated its potent hypnotic effects in animal models, particularly dogs, leading to its introduction as Veronal, the first clinically viable barbiturate sedative.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> This discovery marked the transition from purely synthetic curiosity to therapeutic agent, with barbital&#x27;s diethyl substitution at the 5-position of the barbituric acid ring conferring central nervous system depression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup> Subsequent alkylations and variations on this scaffold enabled the rapid proliferation of barbiturate derivatives.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup></span>
<h3 id="medical-adoption-and-expansion" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Medical Adoption and Expansion<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The first barbiturate adopted for clinical use was barbital (also known as Veronal), whose sedative and hypnotic properties were identified in 1903 by researchers Josef von Mering and Emil Fischer; it was introduced commercially by Bayer in 1904 as a treatment for insomnia and nervousness, offering a safer alternative to existing agents like bromides.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> This marked the initial medical adoption, with barbital rapidly gaining acceptance for its reliability in inducing sleep without the toxicity issues of prior sedatives.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The success of barbital spurred extensive research and synthesis efforts, leading to the development of phenobarbital (Luminal) in 1911 by Heinrich HÃ¶rlein at Bayer, which was marketed in 1912 primarily for sedation but quickly established as an effective anticonvulsant for epilepsy after Alfred Hauptmann demonstrated its ability to suppress seizures without excessive drowsiness.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup> By the 1920s, pharmaceutical companies such as Eli Lilly and Abbott Laboratories accelerated expansion through new derivatives, including amobarbital (Amytal) in 1923 for sedation, secobarbital (Seconal) in 1929, and pentobarbital (Nembutal) in 1930 for both sedation and epilepsy management.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_acqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Further innovation in the 1930s extended barbiturate applications to anesthesia, exemplified by thiopental (Pentothal) introduced by Abbott in 1935, which enabled rapid intravenous induction and revolutionized surgical procedures by allowing shorter-acting, controllable sedation compared to inhalational agents.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Over the early to mid-20th century, more than 2,500 barbiturates were synthesized, with approximately 50 achieving clinical use, dominating therapeutic categories such as anxiolytics, hypnotics, and pre-anesthetic medications from the 1920s until the mid-1950s, when they comprised nearly all available options for these indications.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> This proliferation reflected their perceived efficacy and versatility in addressing central nervous system disorders, though later scrutiny revealed limitations in safety margins.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cdabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<h3 id="decline-due-to-safety-concerns" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Decline Due to Safety Concerns<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The widespread use of barbiturates began to decline in the mid-20th century primarily due to their narrow therapeutic index, which made accidental and intentional overdoses highly lethal; doses producing sedation could readily escalate to respiratory depression, coma, and death without a clear safety margin.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4eabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> Unlike safer alternatives, barbiturates lacked a ceiling effect on CNS depression, leading to frequent fatalitiesâ€”by the 1950s and 1960s, they were implicated in a significant proportion of drug-related suicides and accidental poisonings, with postmortem data showing barbiturates in up to 20-30% of such cases in some Western countries.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8eabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Dependence developed rapidly with chronic use, characterized by tolerance requiring escalating doses and severe withdrawal symptoms including seizures and delirium, further eroding their favorability for long-term therapy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ceabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The introduction of benzodiazepines marked a pivotal shift, as these agents offered anxiolytic and hypnotic effects with markedly lower risks of fatal overdose and dependence; chlordiazepoxide (Librium) was approved by the FDA in 1960, followed by diazepam (Valium) in 1963, rapidly supplanting barbiturates for treating anxiety, insomnia, and seizures due to their wider safety profile and reduced respiratory suppression even at high doses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup> By the late 1960s, clinical guidelines increasingly recommended benzodiazepines over barbiturates, contributing to a steep drop in barbiturate prescriptionsâ€”U.S. data indicate a decline from peak usage in the 1950s to less than 10% of sedative prescriptions by the 1980s.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Regulatory responses amplified this decline amid rising abuse concerns; the U.S. Controlled Substances Act of 1970 classified most barbiturates as Schedule II (high abuse potential) or III drugs, imposing strict prescribing limits and monitoring, while similar controls emerged in Europe following reports of widespread misuse in the 1960s counterculture era.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> These measures, coupled with accumulating evidence of barbiturate-related hospital admissions for toxicityâ€”often involving synergistic effects with alcoholâ€”solidified their relegation to niche roles like refractory epilepsy and anesthesia induction, where their potency remains unmatched but risks are managed in controlled settings.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_afabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<h2 id="pharmacology" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Pharmacology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="mechanism-of-action" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Mechanism of Action<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Barbiturates exert their central nervous system depressant effects primarily through positive allosteric modulation of Î³-aminobutyric acid type A (GABA_A) receptors, the predominant inhibitory receptors in the brain.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> These receptors are ligand-gated chloride channels composed of multiple subunits, including Î±, Î², and Î³ isoforms. Barbiturates bind to a site distinct from the orthosteric GABA-binding pocket, typically involving interactions with the Î± and Î² subunits in the transmembrane domain, which enhances GABA&#x27;s affinity and efficacy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cgqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> This modulation prolongs the duration of chloride channel opening triggered by GABA, increasing chloride influx into postsynaptic neurons, which hyperpolarizes the membrane and suppresses neuronal excitability and firing.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ggqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup> Unlike benzodiazepines, which primarily increase the frequency of channel opening, barbiturates&#x27; prolongation of open time contributes to their greater potency in inducing sedation, hypnosis, and anesthesia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kgqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">At higher concentrations, corresponding to anesthetic or anticonvulsant doses, barbiturates can directly activate GABA_A receptors independently of GABA, further augmenting chloride conductance and inhibitory tone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup> This direct gating is evident in studies using recombinant receptors and neuronal cultures, where compounds like pentobarbital elicit chloride currents without agonist presence, distinguishing barbiturates from weaker modulators.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_chabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> The Î² subunit&#x27;s second and third transmembrane domains, including specific methionine residues, are critical for this barbiturate sensitivity, as demonstrated in mutagenesis experiments.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ghabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Secondary mechanisms include antagonism of excitatory glutamate receptors, such as AMPA/kainate subtypes, and inhibition of glutamate release via presynaptic P/Q-type voltage-gated calcium channels, which reduce excitatory neurotransmission and reinforce overall CNS depression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> However, GABA_A modulation remains the dominant pathway, with potency varying by barbiturate structure and receptor subunit composition; for instance, phenobarbital shows less direct activation than pentobarbital, correlating with differential sedative profiles.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_chqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup></span>
<h3 id="pharmacokinetics-and-metabolism" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Pharmacokinetics and Metabolism<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Barbiturates exhibit variable pharmacokinetics depending on their chemical structure and lipophilicity, influencing their absorption, distribution, metabolism, and excretion. Most are well-absorbed orally, with phenobarbital achieving peak plasma concentrations in 2 to 4 hours and approximately 90% bioavailability in adults, though neonates show reduced bioavailability.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Intravenous administration provides rapid onset for applications like status epilepticus or anesthesia, while rectal or intramuscular routes offer alternatives with varying absorption rates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Distribution is characterized by high lipid solubility, enabling rapid crossing of the blood-brain barrier and extensive tissue penetration, including into the central nervous system.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4jabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Highly lipophilic agents like thiopental and methohexital undergo quick redistribution from brain to peripheral tissues such as muscle and fat, which primarily terminates their ultra-short hypnotic effects after moderate doses (e.g., 5 mg/kg for thiopental), rather than relying on metabolism.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8jabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ajabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup> Larger doses prolong action by saturating redistribution sites, shifting dependence toward slower elimination processes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ejabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup> Plasma protein binding varies, affecting free drug levels available for pharmacological action.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Metabolism occurs predominantly in the liver through oxidation via cytochrome P450 enzymes, converting lipophilic barbiturates into inactive, water-soluble metabolites.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Phenobarbital, a long-acting barbiturate, undergoes extensive hepatic biotransformation and potently induces CYP1A2, CYP2B6, CYP2C9, and CYP3A4/5 enzymes, accelerating its own clearance (autoinduction) and that of co-administered drugs, which contributes to tolerance development as half-life shortens by approximately 4.6 hours per day with chronic use.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Shorter-acting barbiturates like secobarbital follow similar pathways but with faster rates, while ultra-short agents like thiopental exhibit first-order kinetics at low doses but non-linear elimination at higher doses due to saturation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cjqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Primidone, a barbiturate precursor, is metabolized to phenobarbital and phenylethylmalonamide.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gjqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Excretion is primarily renal, with most barbiturates eliminated as metabolites in urine; phenobarbital is unique in that about 25% is excreted unchanged, a process enhanced by urinary alkalinization or osmotic diuresis to ionize the weakly acidic drug and prevent tubular reabsorption.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Elimination rates are faster in younger individuals and slower in the elderly, infants, or those with hepatic impairment, influencing dosing adjustments.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> For thiopental and methohexital, metabolism and excretion play secondary roles to redistribution in determining clinical duration, with methohexital cleared about three times faster than thiopental, reducing accumulation risks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ckabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup> These pharmacokinetic properties underpin the classification of barbiturates by duration of actionâ€”ultra-short (e.g., thiopental, 3-8 minutes hypnotic effect), short-to-intermediate (e.g., secobarbital, 15-40 hours half-life), and long (e.g., phenobarbital, 53-118 hours initially)â€”and explain their potential for drug interactions via enzyme induction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gkabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ikabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup></span>
<h2 id="therapeutic-applications" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Therapeutic Applications<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="human-medical-uses" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Human Medical Uses<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Barbiturates are primarily employed in human medicine for their sedative-hypnotic and anticonvulsant properties, though their use has significantly diminished since the mid-20th century due to narrower therapeutic indices and the availability of safer alternatives like benzodiazepines.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Specific indications include seizure management, where long-acting agents such as phenobarbital remain a first-line option for controlling generalized tonic-clonic seizures and status epilepticus, particularly in neonates and resource-limited settings.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_clqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup> In 2022, the U.S. Food and Drug Administration approved phenobarbital sodium (Sezaby) specifically for treating neonatal seizures in term and preterm infants, highlighting its role in pediatric neurology when other therapies fail.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_glqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">For anesthesia, ultra-short-acting barbiturates like thiopental (pentothal) are used intravenously to induce rapid unconsciousness, typically within 30-45 seconds, in surgical procedures requiring quick onset, though propofol has largely supplanted them in routine practice.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> Preoperative sedation and anxiety relief also utilize intermediate-acting barbiturates such as butabarbital, administered orally or rectally to calm patients prior to surgery, but only short-term to minimize dependence risks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In neonatal care, barbiturates address withdrawal syndromes from intrauterine opioid exposure, with phenobarbital titrated to suppress symptoms like irritability and tremors, often at doses of 3-5 mg/kg/day divided every 12 hours.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Limited applications persist for refractory insomnia unresponsive to non-pharmacologic interventions or safer hypnotics, where short-acting forms like secobarbital may be prescribed cautiously for 1-2 weeks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[34]</sup> Phenobarbital occasionally serves as an adjunct for benzodiazepine withdrawal, leveraging its long half-life (approximately 53-118 hours in adults) to taper dependence gradually.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cmqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup> Overall, contemporary guidelines from bodies like the American Academy of Neurology recommend barbiturates primarily for epilepsy in developing regions or when cost and enzyme-inducing effects (e.g., for metabolizing other anticonvulsants) are advantageous.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gmqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup></span>
<h3 id="veterinary-and-procedural-uses" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Veterinary and Procedural Uses<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">In veterinary medicine, phenobarbital serves as a primary anticonvulsant for managing idiopathic epilepsy and other seizure disorders in dogs and cats, with typical oral dosages of 2-4 mg/kg twice daily achieving therapeutic serum levels of 15-45 Î¼g/mL to suppress seizure activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[38]</sup> The U.S. Food and Drug Administration conditionally approved phenobarbital tablets (Fidoquel-CA1) on September 6, 2023, specifically for controlling seizures associated with idiopathic epilepsy in dogs, reflecting its established efficacy despite potential side effects like sedation, ataxia, and hepatotoxicity requiring periodic monitoring.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_anqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup> In cats, once-daily dosing has demonstrated 88% seizure remission rates without notable compliance issues or adverse effects in controlled studies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_enqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Sodium pentobarbital, often combined with phenytoin sodium (e.g., in products like Euthasol), remains the standard agent for humane euthanasia in small animals such as dogs and cats, administered intravenously at doses of 1 mL per 4.5 kg to induce rapid unconsciousness and cardiac arrest within seconds.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[42]</sup> This method is endorsed by the American Veterinary Medical Association for its reliability and minimal pain, though it poses environmental risks, including secondary poisoning of scavengers like bald eagles via residue in euthanized carcasses, prompting FDA warnings since 2003 and guidelines for proper disposal to prevent tissue rendering.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aoabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_coabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup> Shortages, as occurred in 2021-2022, have necessitated alternatives like intracardiac or intraperitoneal injection in moribund animals, but intravenous pentobarbital is preferred for its speed and humane profile across species including horses, where brain activity flattens within 10 seconds.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_goabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[45]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ioabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[46]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">For procedural sedation and anesthesia induction, ultra-short-acting barbiturates like thiopental are employed in veterinary practice to facilitate rapid onset for short, non-painful interventions or general anesthesia setup, with intravenous doses of 4-8 mg/kg in dogs and cats producing unconsciousness in under 30 seconds but requiring caution in lean breeds due to fat redistribution prolonging recovery.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[48]</sup> However, their use has declined in favor of agents like propofol owing to cardiovascular depression, histamine release, and smoother recoveries, limiting current applications primarily to scenarios where alternatives are unavailable or contraindicated, such as in hypovolemic patients where effects are studied but not routinely recommended.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aoqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_coqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[50]</sup> In large animals, thiobarbiturates are occasionally combined with other agents for induction, though antithyroid effects in hyperthyroid patients warrant avoidance.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_goqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[51]</sup></span>
<h2 id="risks-and-adverse-effects" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Risks and Adverse Effects<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="acute-side-effects-and-toxicity" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Acute Side Effects and Toxicity<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Acute side effects of barbiturates at therapeutic doses primarily involve central nervous system depression, manifesting as drowsiness, dizziness, ataxia, nystagmus, and slurred speech.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> These effects arise from the drugs&#x27; enhancement of GABA_A receptor activity, leading to neuronal hyperpolarization and reduced excitability across various brain regions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> Paradoxical excitation, such as agitation or hyperactivity, can occur particularly in elderly patients or children, though this is less common than sedative effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Toxicity emerges with doses exceeding therapeutic levels, due to barbiturates&#x27; narrow therapeutic index, where the margin between effective and lethal concentrations is smallâ€”exemplified by phenobarbital&#x27;s range of 10-30 mg/L for efficacy versus higher levels causing severe impairment.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> Initial toxic symptoms include profound sedation, impaired coordination, clouded mentation, and hypotension from vasodilation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> As plasma concentrations rise, progression to coma, respiratory depression progressing to apnea, and cardiovascular instability ensues, with hypoventilation causing hypoxia and acidosis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Severe overdose, often intentional but also accidental given the drugs&#x27; pharmacokinetics allowing accumulation in adipose tissue, leads to multi-organ failure risks including renal impairment from hypotension and rhabdomyolysis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> Approximately 10% of barbiturate overdoses result in fatality, primarily from respiratory arrest or secondary complications like aspiration pneumonia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup> Lethality is exacerbated by co-ingestion with alcohol or opioids, which synergistically depress respiration via shared GABAergic and mu-opioid pathways.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_crabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> Barbiturates&#x27; zero-order elimination kinetics further heightens toxicity risk, as clearance becomes saturated, prolonging effects unpredictably.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_grabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup></span>
<h3 id="dependence-tolerance-and-withdrawal" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Dependence, Tolerance, and Withdrawal<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Barbiturates induce tolerance through adaptive changes in the central nervous system, primarily involving downregulation of GABAA receptor sensitivity and alterations in chloride channel function, necessitating higher doses to achieve equivalent sedative or hypnotic effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[54]</sup> This tolerance develops rapidly with regular use, often within days to weeks, particularly to the mood-altering and respiratory depressant effects, though anticonvulsant efficacy may persist longer.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_asabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Physical dependence arises from prolonged exposure, even at therapeutic doses, as the body adapts to the drug&#x27;s suppression of neuronal excitability, leading to a state where cessation disrupts homeostasis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4sqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Psychological dependence accompanies this, driven by reinforcement of anxiolytic effects, with risks escalating with duration and dosage; for instance, phenobarbital use beyond short-term indications frequently results in dependence requiring tapered discontinuation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8sqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_asqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[55]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Withdrawal manifests 2 to 4 days after abrupt cessation in dependent individuals, progressing from mild autonomic hyperactivity to severe neurological symptoms including anxiety, tremor, nausea, insomnia, and potentially life-threatening seizures or delirium tremens-like states due to unchecked excitatory neurotransmission.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[57]</sup> The syndrome&#x27;s severity correlates with prior dosage and chronicity, often exceeding that of benzodiazepines because of barbiturates&#x27; steeper dose-response curve and lack of ceiling effect on GABA enhancement, with mortality risks from status epilepticus or cardiovascular collapse if unmanaged.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_atabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup> Management typically involves gradual tapering with long-acting barbiturates or substitution with benzodiazepines under medical supervision to mitigate rebound hyperexcitability.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_etabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gtabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup></span>
<h3 id="overdose-management-and-lethality" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Overdose Management and Lethality<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Barbiturates exhibit a narrow therapeutic index, with the margin between effective doses and those causing severe toxicity or death being particularly small, predisposing users to life-threatening overdose even at modestly supratherapeutic levels.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4uabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> Overdose primarily manifests through profound central nervous system depression, leading to coma, respiratory failure via hypoventilation and apnea, hypotension from myocardial depression and vasodilation, and potential cardiac arrhythmias; these effects are exacerbated by co-ingestion with alcohol, opioids, or benzodiazepines due to additive respiratory suppression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8uabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> The minimum lethal oral dose varies by compound and tolerance, typically ranging from 2-3 grams for short-acting agents like pentobarbital to 6-10 grams for long-acting phenobarbital in non-tolerant individuals, though chronic users may survive higher amounts due to developed tolerance.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cuabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[59]</sup> Case fatality rates in suicidal overdoses involving barbiturates have been reported as 5.8-12.2%, higher than for many other drug classes, reflecting their potent depressant effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_guabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[60]</sup> With modern supportive care, in-hospital mortality remains low at 0.5-2%, but untreated or delayed cases carry high lethality, particularly in the elderly or those with comorbidities like cardiovascular disease.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kuabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ouabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Management of barbiturate overdose centers on supportive measures, as no specific antidote exists, unlike benzodiazepines which respond to flumazenil.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> Initial stabilization follows advanced trauma life support protocols, prioritizing airway protection via endotracheal intubation if Glasgow Coma Scale scores indicate risk of aspiration, mechanical ventilation for respiratory depression, and circulatory support with intravenous fluids or vasopressors for hypotension.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[61]</sup> Gastrointestinal decontamination with activated charcoal is recommended within 1-2 hours of ingestion to reduce absorption, particularly effective for long-acting barbiturates; multiple-dose regimens may further enhance elimination via enterohepatic recirculation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cuqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup> Patients require continuous monitoring of vital signs, electrocardiography for arrhythmias, and laboratory assessment of electrolytes, renal function, and drug levels, with alkaline diuresis historically used but now largely supplanted by extracorporeal methods.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_guqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[61]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">For severe intoxications, especially with phenobarbital where half-life prolongation in overdose can extend coma to days, enhanced elimination techniques such as hemodialysis or hemoperfusion are indicated to accelerate clearance, reducing coma duration and complications like pneumonia or rhabdomyolysis. These interventions are prioritized in cases with levels exceeding 100 mcg/mL for phenobarbital or refractory hypotension, with evidence showing reduced mortality when applied early.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4vabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[62]</sup> Naloxone may be trialed if opioids are suspected as co-ingestants but lacks efficacy against pure barbiturate effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8vabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[63]</sup> Recovery typically involves intensive care observation until spontaneous ventilation resumes, with full neurological assessment to detect sequelae like persistent cognitive impairment.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cvabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[61]</sup></span>
<h2 id="comparative-efficacy-and-safety" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Comparative Efficacy and Safety<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="barbiturates-versus-benzodiazepines" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Barbiturates Versus Benzodiazepines<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Barbiturates and benzodiazepines both potentiate the inhibitory effects of gamma-aminobutyric acid (GABA) at GABA_A receptors in the central nervous system, but differ in their binding sites and downstream effects. Barbiturates bind to a distinct site on the GABA_A receptor, prolonging the duration of chloride channel opening, which leads to deeper and more prolonged neuronal hyperpolarization.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_50qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup> In contrast, benzodiazepines bind to a specific high-affinity site on the GABA_A receptor, increasing the frequency of channel opening without prolonging individual openings, resulting in less intense suppression of neuronal activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_90qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup> This mechanistic distinction contributes to barbiturates&#x27; greater potency and broader suppression of central nervous system functions, including at non-GABAergic synapses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A primary clinical difference lies in their therapeutic indices and overdose risks. Barbiturates exhibit a narrow therapeutic index, where the dose required for therapeutic effect is close to the toxic dose, heightening the risk of respiratory depression, hypotension, and coma even at standard doses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_51abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup> Overdose with barbiturates frequently proves fatal due to profound respiratory arrest and cardiovascular collapse, with no effective reversal agent available beyond supportive care.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_91abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> Benzodiazepines, however, possess a wider therapeutic index, with lethal doses typically 100- to 500-fold higher than therapeutic ones, and rarely cause death when taken alone, though they can exacerbate risks when combined with other depressants like alcohol or opioids.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[66]</sup> Flumazenil serves as a specific antagonist for benzodiazepine overdose, enabling reversal in many cases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>






























<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Aspect</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Barbiturates</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Benzodiazepines</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><strong>Therapeutic Index</strong></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Narrow; high overdose lethality</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Wide; lower fatal overdose risk alone</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><strong>Respiratory Depression</strong></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Dose-dependent and profound, even at therapeutic levels</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Milder; ceiling effect limits severity</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><strong>Dependence Potential</strong></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">High; rapid tolerance development</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">High but slower onset; cross-tolerance possible</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><strong>Clinical Preference</strong></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Limited to refractory seizures, anesthesia induction</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">First-line for anxiety, acute seizures, sedation</span></td></tr></tbody></table></div>
<span class="mb-4 block break-words text-[1em] leading-7">In terms of efficacy, benzodiazepines demonstrate comparable or superior anxiolytic, anticonvulsant, and sedative effects for most indications with reduced side effects, leading to their preferential use in anxiety disorders, insomnia, and procedural sedation since the 1960s.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_52abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[67]</sup> Barbiturates retain niche roles, such as in refractory status epilepticus or certain veterinary applications, where their deeper suppression proves necessary after benzodiazepine failure.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_92abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Both classes induce tolerance and physical dependence with chronic use, but barbiturate withdrawal carries higher risks of seizures and delirium due to more severe rebound hyperexcitability.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[68]</sup> The replacement of barbiturates by benzodiazepines in routine medical practice stemmed from these safety advantages, reducing accidental deaths and improving outpatient manageability.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[69]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_j2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[67]</sup></span>
<h3 id="reasons-for-therapeutic-replacement" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Reasons for Therapeutic Replacement<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Barbiturates have been progressively replaced in therapeutic applications by benzodiazepines and other sedative-hypnotics primarily due to their narrow therapeutic index, which is the ratio between the dose producing the desired effect and the dose causing toxicity. This narrow margin results in a small difference between effective sedative or anticonvulsant doses and those leading to severe respiratory depression or coma, elevating the risk of accidental or intentional overdose.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_53abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[70]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_73abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_93abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[71]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In contrast, benzodiazepines exhibit a wider therapeutic index, allowing for safer administration with reduced likelihood of fatal outcomes even at higher doses, as they cause less profound suppression of respiratory drive. Barbiturates&#x27; mechanism of prolonging GABA_A receptor channel opening leads to maximal channel activation at high doses, lacking a ceiling effect that benzodiazepines possess, which contributes to their higher lethality in overdose scenarios.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_53qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[72]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_73qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[73]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_93qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[66]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The propensity for rapid tolerance, physical dependence, and severe withdrawal symptoms further diminished barbiturates&#x27; favorability, as chronic use necessitates escalating doses to maintain efficacy, heightening abuse potential and complicating discontinuation. Benzodiazepines, while not devoid of dependence risks, offer more manageable withdrawal profiles and antagonists like flumazenil for reversal, facilitating their preference in treating anxiety, insomnia, and procedural sedation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_54abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_74abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[68]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_94abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[74]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">This shift accelerated in the mid-20th century following the introduction of benzodiazepines in the 1960s, with barbiturate prescriptions declining sharply over subsequent decades as clinical evidence highlighted their inferior safety relative to alternatives like non-benzodiazepine hypnotics for sleep disorders. Despite retained niche uses in refractory epilepsy or certain anesthetics, the overall therapeutic displacement reflects empirical prioritization of agents minimizing iatrogenic harm.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_54qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[75]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_74qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_94qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup></span>
<h2 id="controversies-and-societal-debates" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Controversies and Societal Debates<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="truth-serum-applications-and-limitations" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Truth Serum Applications and Limitations<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Barbiturates such as sodium amytal (amobarbital) and sodium thiopental have been employed in so-called &quot;truth serum&quot; applications since the early 20th century, primarily to facilitate interrogations by reducing psychological inhibitions and inducing a hypnotic, confessional state.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_56abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup> These drugs were administered intravenously to suspects or witnesses in psychiatric narcoanalysis sessions, with the aim of eliciting suppressed memories or admissions during states of sedation where critical faculties are impaired.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_96abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[77]</sup> Historical use peaked during World War II and the Cold War, including by U.S. military intelligence and the CIA&#x27;s MKUltra program (1953â€“1973), which tested sodium thiopental among other agents for extracting information from prisoners or spies through chemical interrogation techniques.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[78]</sup> Pioneering work by University of Wisconsin psychiatrist William Bleckwenn in the 1930s demonstrated sodium amytal&#x27;s potential to break catatonic states in schizophrenia patients, leading to its extension into forensic contexts despite lacking empirical validation for veracity enhancement.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[79]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Proponents claimed these barbiturates worked by depressing the central nervous system, lowering resistance to suggestion and promoting free association akin to hypnosis, as observed in clinical trials where subjects became unusually loquacious under dosages of 200â€“600 mg.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_56qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[80]</sup> In practice, applications extended to police investigations in the U.S. and Europe until the mid-20th century, with isolated cases like the 1922 use of scopolamine (a related alkaloid, later supplemented by barbiturates) in Texas criminal probes yielding purported confessions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_96qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[81]</sup> However, declassified CIA assessments from the 1950sâ€“1960s, including those under MKUltra Subproject 68, revealed inconsistent results, with drugs often producing rambling narratives rather than reliable disclosures.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[78]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Despite these applications, barbiturates do not function as genuine truth serums, as no pharmacological agent can compel veridical statements or override willful deception, according to evaluations by intelligence agencies and pharmacologists.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_57abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[78]</sup> Subjects under influence exhibit heightened suggestibility, confabulation, and fantasy production, leading to fabricated details indistinguishable from facts; for instance, a 2013 experimental interrogation with sodium thiopental resulted in voluble but inaccurate responses from the subject.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_97abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[80]</sup> Scientific reviews confirm that while barbiturates disrupt executive function and inhibitory controlsâ€”via GABA receptor potentiationâ€”they fail to differentiate truth from falsehood, with error rates exceeding 50% in controlled tests due to residual cognitive biases and motivational lying.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[77]</sup> Courts worldwide, including U.S. federal rulings from the 1960s onward, deem such evidence inadmissible owing to unreliability and violation of due process, as affirmed in cases like <em>Townsend v. Sain</em> (1963).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_l7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[82]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Additional limitations include ethical prohibitions against non-consensual use, as outlined in psychiatric guidelines since the 1950s, and physiological risks such as respiratory depression or paradoxical excitation, which can terminate sessions prematurely or induce amnesia, further obscuring any potential insights.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_57qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[83]</sup> Post-MKUltra disclosures in 1977 Senate hearings highlighted abuses, including unwitting dosing leading to psychological harm, underscoring the causal disconnect between sedation and truth extraction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_97qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[84]</sup> Modern consensus, informed by neuropharmacology, attributes any confessional effects to disinhibition rather than enhanced honesty, rendering barbiturates obsolete for interrogative purposes in favor of psychological and technological alternatives.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup></span>
<h3 id="role-in-euthanasia-assisted-suicide-and-capital-punishment" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Role in Euthanasia, Assisted Suicide, and Capital Punishment<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Barbiturates, particularly pentobarbital and secobarbital, have been employed in jurisdictions permitting euthanasia and assisted suicide due to their capacity to induce rapid unconsciousness followed by respiratory arrest at high doses. In physician-assisted suicide under Oregon&#x27;s Death with Dignity Act, eligible terminally ill patients receive prescriptions for secobarbital (typically 9-10 grams, equivalent to 90-100 capsules crushed and dissolved in liquid) or pentobarbital for self-administration, resulting in death within minutes to hours in the majority of cases reported annually since the law&#x27;s enactment in 1997.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_58qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[85]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_98qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[86]</sup> In Switzerland, organizations such as Dignitas facilitate assisted suicide by providing oral pentobarbital solutions (around 15 grams), which patients ingest to achieve coma and subsequent cardiorespiratory failure, with protocols established since the early 2000s.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[87]</sup> For active euthanasia in the Netherlands and Belgium, where physician administration is legal, barbiturates like pentobarbital (2-10 grams intravenously) are standard to first render the patient unconscious before additional agents ensure death, aligning with national guidelines emphasizing reliability and minimal distress.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[88]</sup> These applications leverage barbiturates&#x27; pharmacological mechanism of enhancing GABA-mediated inhibition, leading to profound sedation and suppression of vital functions, though survival has occurred rarely from sublethal ingestions due to vomiting or incomplete absorption.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_l8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[89]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In capital punishment, barbiturates serve as the primary anesthetic in lethal injection protocols across U.S. states and federal executions, intended to ensure unconsciousness prior to cardiac arrest from subsequent drugs. Pentobarbital emerged as a single-drug alternative around 2010 amid shortages of sodium thiopental, with states like Texas administering 5 grams intravenously to condemned individuals, causing death via central nervous system and respiratory depression within 10-20 minutes when properly dosed.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_59abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup> The U.S. federal government adopted a one-drug pentobarbital protocol in 2019 for executions resumed after a 17-year hiatus, sourcing the compound domestically to bypass European export bans imposed since 2011 on drugs intended for lethal use.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_99abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[91]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[92]</sup> Compounding pharmacies have become key suppliers for states including Missouri and Texas, producing pentobarbital in unmarked facilities under secrecy laws to evade manufacturer refusals and legal challenges, with Texas procuring batches from local pharmacies like Rite-Away from 2019 through at least 2023.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[93]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_l9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[94]</sup> Concerns over sourcing reliability have prompted some states to stockpile or experiment with alternatives, yet pentobarbital remains prevalent for its proven lethality in controlled intravenous administration.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_p9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[95]</sup></span>
<h2 id="legal-and-regulatory-framework" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Legal and Regulatory Framework<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="controlled-substance-status" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Controlled Substance Status<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">In the United States, barbiturates are classified as controlled substances under the Controlled Substances Act of 1970, administered by the Drug Enforcement Administration (DEA), with scheduling determined by abuse potential, medical utility, and dependence liability. Short-acting barbiturates such as secobarbital and pentobarbital are placed in Schedule II, reflecting their high potential for abuse alongside accepted uses in anesthesia and acute sedation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[96]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[97]</sup> Intermediate-acting compounds like amobarbital also fall under Schedule II.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_daqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Longer-acting barbiturates, including phenobarbital used for epilepsy management, are scheduled in Schedule IV due to comparatively lower abuse risk.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_haqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[96]</sup> Certain formulations, such as those containing butalbital, are classified in Schedule III.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_laqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[98]</sup> Schedule II and III status mandates strict prescription requirements, including no refills without new authorization and inventory tracking for manufacturers and pharmacies, while Schedule IV allows limited refills under medical supervision.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_paqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Internationally, barbiturates are regulated under the 1971 United Nations Convention on Psychotropic Substances, which lists twelve specific compounds across its Schedules II, III, and IV based on therapeutic value versus risk of misuse. Schedule II includes high-potency sedatives like secobarbital and amobarbital, requiring stringent import/export controls and medical justifications; Schedule III covers intermediates like pentobarbital; and Schedule IV encompasses milder agents such as phenobarbital, permitting broader medical access with safeguards against diversion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[100]</sup> Parties to the convention, numbering over 180 nations as of 2021, must limit production to medical and scientific needs, enforce licensing, and report statistics to the International Narcotics Control Board.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[101]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In the United Kingdom, barbiturates are designated Class B drugs under the Misuse of Drugs Act 1971, carrying penalties of up to 5 years imprisonment and unlimited fines for unlawful possession or supply, with most placed in Schedule 3 of the Misuse of Drugs Regulations 2001 to restrict non-medical handling.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[102]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[103]</sup> Prescriptions require safe custody storage and detailed record-keeping, prohibiting private imports without Home Office approval. In Canada, they are controlled under the Controlled Drugs and Substances Act as narcotics or designated substances, necessitating prescriptions and compliance with federal monitoring for cross-border transport.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[104]</sup> European Union member states align with UN schedules, implementing national variations such as Schedule IV classifications for phenobarbital in several countries, emphasizing veterinary and limited human therapeutic exemptions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> These frameworks stem from documented risks of overdose and dependence established in mid-20th-century epidemiological data, prioritizing harm reduction through regulated access over prohibition.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[105]</sup></span>
<h3 id="patterns-of-non-medical-use" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Patterns of Non-Medical Use<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Non-medical use of barbiturates primarily involves seeking sedative, euphoric, or disinhibiting effects, often to counteract stimulation from other substances or to induce relaxation akin to alcohol intoxication. Such misuse became evident in the 1930s, with users reporting &quot;drunk-like&quot; states from oral ingestion, escalating through the mid-20th century as prescriptions proliferated for anxiety and insomnia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[106]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> By the 1960s and 1970s, recreational patterns intensified, including polydrug combinations with alcohol, opioids, or stimulants like amphetamines to balance highs or enhance sedation, though this amplified overdose lethality due to synergistic respiratory depression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[107]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[97]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Abuse methods typically entail oral consumption of diverted prescriptions, with higher-risk patterns featuring intravenous injection in dependent users to achieve rapid onset, though this is less common today owing to availability constraints.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[108]</sup> Users, frequently those already addicted to other depressants or stimulants, escalate doses to tolerate tolerance, leading to cycles of bingeing followed by withdrawal-driven compulsion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[109]</sup> Historical data from U.S. congressional inquiries in the early 1970s highlighted barbiturates&#x27; role in widespread sedative abuse, often among urban populations and polysubstance users, prompting tighter controls.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ddabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[110]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Current patterns reflect sharp decline since the 1970s, driven by prescription reductions, benzodiazepine substitution, and Schedule II/III classifications under the Controlled Substances Act, rendering non-medical access sporadic via illicit diversion or stockpiles. In 2018, an estimated 405,000 Americans aged 12 and older reported past-year misuse, representing under 0.2% of that population, with adolescent involvement minimal at about 2% of 12th graders.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[63]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[111]</sup> Lifetime exposure to abuse affects roughly 9% of Americans, but active patterns cluster among older adults with legacy prescriptions or those in opioid recovery substituting for withdrawal symptoms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bdqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[112]</sup> Drug testing data confirm rarity, with barbiturate positives comprising only 1.1% of abuse panels over extended periods.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fdqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[113]</sup> Despite low prevalence, residual risks persist in polysubstance contexts, underscoring barbiturates&#x27; niche but hazardous non-medical niche.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_jdqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[114]</sup></span>
<h2 id="specific-compounds-and-examples" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Specific Compounds and Examples<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7"></span>
<span class="mb-4 block break-words text-[1em] leading-7">Barbiturates are classified by duration of action, influencing their clinical applications: ultra-short-acting for induction of anesthesia, short- to intermediate-acting for hypnosis and sedation, and long-acting for seizure control.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Phenobarbital, a long-acting barbiturate with a half-life of 37 to 140 hours, is primarily used as an anticonvulsant for epilepsy and febrile seizures in children, and occasionally for preoperative sedation or alcohol withdrawal management.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Secobarbital, a short-acting compound with effects lasting 15 to 50 hours in terms of elimination half-life, was historically prescribed as a hypnotic for short-term insomnia treatment but is now rarely used due to risks of dependence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bfqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dfqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Pentobarbital, another short- to intermediate-acting barbiturate, serves as a sedative-hypnotic for preoperative anxiety, seizure control in emergencies, and has been employed in euthanasia protocols and capital punishment in some jurisdictions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[97]</sup> Thiopental, an ultra-short-acting intravenous agent, is utilized for rapid induction of general anesthesia, providing unconsciousness within seconds, though its use has declined with safer alternatives.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Butalbital, an intermediate-acting barbiturate, is combined with caffeine and analgesics in formulations like Fioricet for tension headaches, despite limited evidence of superior efficacy over non-barbiturate options and potential for misuse.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[97]</sup> Primidone, a barbiturate derivative, functions as an anticonvulsant for essential tremors and epilepsy, metabolized partly to phenobarbital, with a shorter half-life of 5 to 15 hours.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bgqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dgqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>



































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Compound</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Duration of Action</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Primary Uses</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Phenobarbital</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Long-acting</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Anticonvulsant for epilepsy</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mdhabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Secobarbital</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Short-acting</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Hypnotic for insomnia (historical)</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mlhabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Pentobarbital</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Short- to intermediate-acting</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Sedation, seizures, euthanasia</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mthabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[97]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Thiopental</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Ultra-short-acting</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Anesthesia induction</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_n5habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Butalbital</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Intermediate-acting</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Headache relief in combinations</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ndhabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></td></tr></tbody></table></div></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="https://www.ncbi.nlm.nih.gov/books/NBK539731/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK539731/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK539731/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC1079678/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1079678/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC1079678/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/9255991/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/9255991/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/9255991/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK499875/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK499875/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK499875/</a></span></div></li><li id="https://pubchem.ncbi.nlm.nih.gov/compound/Barbituric-Acid" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/Barbituric-Acid" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubchem.ncbi.nlm.nih.gov/compound/Barbituric-Acid</a></span></div></li><li id="https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/barbituric-acid" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/barbituric-acid" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/barbituric-acid</a></span></div></li><li id="https://www.pharmacy180.com/article/barbiturates-2101/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.pharmacy180.com/article/barbiturates-2101/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.pharmacy180.com/article/barbiturates-2101/</a></span></div></li><li id="https://www.euda.europa.eu/publications/drug-profiles/barbiturates_en" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.euda.europa.eu/publications/drug-profiles/barbiturates_en" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.euda.europa.eu/publications/drug-profiles/barbiturates_en</a></span></div></li><li id="https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_%28OpenStax%29/22%253A_Carbonyl_Alpha-Substitution_Reactions/22.08%253A_Chemistry_MattersBarbiturates" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_%28OpenStax%29/22%253A_Carbonyl_Alpha-Substitution_Reactions/22.08%253A_Chemistry_MattersBarbiturates" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_%28OpenStax%29/22%253A_Carbonyl_Alpha-Substitution_Reactions/22.08%253A_Chemistry_MattersBarbiturates</a></span></div></li><li id="https://chem.libretexts.org/Bookshelves/Biological_Chemistry/Supplemental_Modules_%28Biological_Chemistry%29/Pharmaceuticals/Barbiturates_and_Benzodiazepines" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://chem.libretexts.org/Bookshelves/Biological_Chemistry/Supplemental_Modules_%28Biological_Chemistry%29/Pharmaceuticals/Barbiturates_and_Benzodiazepines" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://chem.libretexts.org/Bookshelves/Biological_Chemistry/Supplemental_Modules_%28Biological_Chemistry%29/Pharmaceuticals/Barbiturates_and_Benzodiazepines</a></span></div></li><li id="https://accessanesthesiology.mhmedical.com/content.aspx?sectionid=61587846&amp;bookid=974" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://accessanesthesiology.mhmedical.com/content.aspx?sectionid=61587846&amp;bookid=974" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://accessanesthesiology.mhmedical.com/content.aspx?sectionid=61587846&amp;bookid=974</a></span></div></li><li id="https://accessemergencymedicine.mhmedical.com/content.aspx?bookid=2353&amp;sectionid=220744425" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://accessemergencymedicine.mhmedical.com/content.aspx?bookid=2353&amp;sectionid=220744425" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://accessemergencymedicine.mhmedical.com/content.aspx?bookid=2353&amp;sectionid=220744425</a></span></div></li><li id="https://my.clevelandclinic.org/health/treatments/23271-barbiturates" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://my.clevelandclinic.org/health/treatments/23271-barbiturates" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://my.clevelandclinic.org/health/treatments/23271-barbiturates</a></span></div></li><li id="https://www.sciencedirect.com/topics/medicine-and-dentistry/barbiturate" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/barbiturate" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/topics/medicine-and-dentistry/barbiturate</a></span></div></li><li id="https://www.drugs.com/drug-class/barbiturates.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.drugs.com/drug-class/barbiturates.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.drugs.com/drug-class/barbiturates.html</a></span></div></li><li id="https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/barbiturate" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/barbiturate" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/barbiturate</a></span></div></li><li id="https://www.ch.ic.ac.uk/rzepa/mim/drugs/html/barbiturate.htm" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ch.ic.ac.uk/rzepa/mim/drugs/html/barbiturate.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ch.ic.ac.uk/rzepa/mim/drugs/html/barbiturate.htm</a></span></div></li><li id="https://www.general-anaesthesia.com/people/adolf-baeyer.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.general-anaesthesia.com/people/adolf-baeyer.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.general-anaesthesia.com/people/adolf-baeyer.html</a></span></div></li><li id="https://www.news-medical.net/health/Barbiturate-History.aspx" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.news-medical.net/health/Barbiturate-History.aspx" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.news-medical.net/health/Barbiturate-History.aspx</a></span></div></li><li id="https://pubs.acs.org/doi/pdf/10.1021/ed028p524" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubs.acs.org/doi/pdf/10.1021/ed028p524" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubs.acs.org/doi/pdf/10.1021/ed028p524</a></span></div></li><li id="https://pubsapp.acs.org/cen/coverstory/83/8325/8325phenobarbital.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubsapp.acs.org/cen/coverstory/83/8325/8325phenobarbital.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubsapp.acs.org/cen/coverstory/83/8325/8325phenobarbital.html</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/23205960/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/23205960/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/23205960/</a></span></div></li><li id="https://emedicine.medscape.com/article/813155-overview" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://emedicine.medscape.com/article/813155-overview" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://emedicine.medscape.com/article/813155-overview</a></span></div></li><li id="https://my.clevelandclinic.org/health/treatments/24570-benzodiazepines-benzos" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://my.clevelandclinic.org/health/treatments/24570-benzodiazepines-benzos" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://my.clevelandclinic.org/health/treatments/24570-benzodiazepines-benzos</a></span></div></li><li id="https://go.drugbank.com/drugs/DB01341" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://go.drugbank.com/drugs/DB01341" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://go.drugbank.com/drugs/DB01341</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/23205959/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/23205959/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/23205959/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC1161000/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1161000/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC1161000/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0261988121001907" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0261988121001907" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0261988121001907</a></span></div></li><li id="https://medlineplus.gov/druginfo/meds/a682007.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://medlineplus.gov/druginfo/meds/a682007.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://medlineplus.gov/druginfo/meds/a682007.html</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK532277/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK532277/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK532277/</a></span></div></li><li id="https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215910s000lbl.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215910s000lbl.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215910s000lbl.pdf</a></span></div></li><li id="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/000793s026lbl.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/000793s026lbl.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/000793s026lbl.pdf</a></span></div></li><li id="https://www.news-medical.net/health/What-are-Barbiturates.aspx" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.news-medical.net/health/What-are-Barbiturates.aspx" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.news-medical.net/health/What-are-Barbiturates.aspx</a></span></div></li><li id="https://www.drugs.com/mtm/phenobarbital.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.drugs.com/mtm/phenobarbital.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.drugs.com/mtm/phenobarbital.html</a></span></div></li><li id="https://www.epilepsy.com/tools-resources/seizure-medication-list/phenobarbital" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.epilepsy.com/tools-resources/seizure-medication-list/phenobarbital" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.epilepsy.com/tools-resources/seizure-medication-list/phenobarbital</a></span></div></li><li id="https://veterinarypartner.vin.com/doc/?id=4951404&amp;pid=19239" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://veterinarypartner.vin.com/doc/?id=4951404&amp;pid=19239" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://veterinarypartner.vin.com/doc/?id=4951404&amp;pid=19239</a></span></div></li><li id="https://www.petmd.com/pet-medication/phenobarbital-dogs-and-cats" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.petmd.com/pet-medication/phenobarbital-dogs-and-cats" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.petmd.com/pet-medication/phenobarbital-dogs-and-cats</a></span></div></li><li id="https://www.fda.gov/animal-veterinary/cvm-updates/fda-conditionally-approves-phenobarbital-tablets-control-seizures-dogs-idiopathic-epilepsy" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.fda.gov/animal-veterinary/cvm-updates/fda-conditionally-approves-phenobarbital-tablets-control-seizures-dogs-idiopathic-epilepsy" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.fda.gov/animal-veterinary/cvm-updates/fda-conditionally-approves-phenobarbital-tablets-control-seizures-dogs-idiopathic-epilepsy</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10812035/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10812035/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10812035/</a></span></div></li><li id="https://www.vet.cornell.edu/facts-about-euthanasia-small-animals" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.vet.cornell.edu/facts-about-euthanasia-small-animals" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.vet.cornell.edu/facts-about-euthanasia-small-animals</a></span></div></li><li id="https://vet-us.virbac.com/home/products/in-clinic-use/euthasol-pentobarbital-sodium-an.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://vet-us.virbac.com/home/products/in-clinic-use/euthasol-pentobarbital-sodium-an.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://vet-us.virbac.com/home/products/in-clinic-use/euthasol-pentobarbital-sodium-an.html</a></span></div></li><li id="https://pubs.usgs.gov/publication/2001158" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubs.usgs.gov/publication/2001158" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubs.usgs.gov/publication/2001158</a></span></div></li><li id="https://www.fws.gov/story/help-prevent-euthanasia-drugs-killing-bald-eagles-and-other-wildlife" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.fws.gov/story/help-prevent-euthanasia-drugs-killing-bald-eagles-and-other-wildlife" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.fws.gov/story/help-prevent-euthanasia-drugs-killing-bald-eagles-and-other-wildlife</a></span></div></li><li id="https://www.avma.org/blog/pentobarbital-back-orders-and-potential-alternatives" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.avma.org/blog/pentobarbital-back-orders-and-potential-alternatives" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.avma.org/blog/pentobarbital-back-orders-and-potential-alternatives</a></span></div></li><li id="https://compneuro.vetmed.ucdavis.edu/research/humane-euthanasia" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://compneuro.vetmed.ucdavis.edu/research/humane-euthanasia" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://compneuro.vetmed.ucdavis.edu/research/humane-euthanasia</a></span></div></li><li id="https://www.petplace.com/article/drug-library/drug-library/library/thiopental-pentothal-for-dogs-and-cats" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.petplace.com/article/drug-library/drug-library/library/thiopental-pentothal-for-dogs-and-cats" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.petplace.com/article/drug-library/drug-library/library/thiopental-pentothal-for-dogs-and-cats</a></span></div></li><li id="https://veteriankey.com/injectable-anesthetic-agents/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://veteriankey.com/injectable-anesthetic-agents/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://veteriankey.com/injectable-anesthetic-agents/</a></span></div></li><li id="https://wildernessvet.com/veterinary-anesthesia-demystified/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://wildernessvet.com/veterinary-anesthesia-demystified/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://wildernessvet.com/veterinary-anesthesia-demystified/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/2053727/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/2053727/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/2053727/</a></span></div></li><li id="https://www.westernu.edu/mediafiles/veterinary/vet-anesthesia-analgesia/pharmacology-intravenous-anesthetic-agents-dissociatives.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.westernu.edu/mediafiles/veterinary/vet-anesthesia-analgesia/pharmacology-intravenous-anesthetic-agents-dissociatives.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.westernu.edu/mediafiles/veterinary/vet-anesthesia-analgesia/pharmacology-intravenous-anesthetic-agents-dissociatives.pdf</a></span></div></li><li id="https://medlineplus.gov/ency/article/000951.htm" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://medlineplus.gov/ency/article/000951.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://medlineplus.gov/ency/article/000951.htm</a></span></div></li><li id="https://drugabuse.com/drugs/barbiturates/overdose/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://drugabuse.com/drugs/barbiturates/overdose/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://drugabuse.com/drugs/barbiturates/overdose/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/0024320596001993" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/0024320596001993" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/0024320596001993</a></span></div></li><li id="https://addictionresource.com/drugs/barbiturates/dependence/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://addictionresource.com/drugs/barbiturates/dependence/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://addictionresource.com/drugs/barbiturates/dependence/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/10349206/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/10349206/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/10349206/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S0006899304003737" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S0006899304003737" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S0006899304003737</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC1268024/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1268024/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC1268024/</a></span></div></li><li id="https://accessmedicine.mhmedical.com/content.aspx?bookid=2284&amp;sectionid=248383642" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://accessmedicine.mhmedical.com/content.aspx?bookid=2284&amp;sectionid=248383642" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://accessmedicine.mhmedical.com/content.aspx?bookid=2284&amp;sectionid=248383642</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7090840/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7090840/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7090840/</a></span></div></li><li id="https://emedicine.medscape.com/article/813155-treatment" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://emedicine.medscape.com/article/813155-treatment" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://emedicine.medscape.com/article/813155-treatment</a></span></div></li><li id="https://www.uptodate.com/contents/barbiturate-phenobarbital-poisoning" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.uptodate.com/contents/barbiturate-phenobarbital-poisoning" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.uptodate.com/contents/barbiturate-phenobarbital-poisoning</a></span></div></li><li id="https://americanaddictioncenters.org/barbiturate" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://americanaddictioncenters.org/barbiturate" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://americanaddictioncenters.org/barbiturate</a></span></div></li><li id="https://www.ardurecoverycenter.com/barbiturates-vs-benzodiazepines/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ardurecoverycenter.com/barbiturates-vs-benzodiazepines/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ardurecoverycenter.com/barbiturates-vs-benzodiazepines/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3684331/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3684331/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3684331/</a></span></div></li><li id="https://www.tresvistasrecovery.com/services/outpatient-benzo-detox/barbiturates-vs-benzodiazepines/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.tresvistasrecovery.com/services/outpatient-benzo-detox/barbiturates-vs-benzodiazepines/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.tresvistasrecovery.com/services/outpatient-benzo-detox/barbiturates-vs-benzodiazepines/</a></span></div></li><li id="https://www.gratitudelodge.com/drug-info/vs/barbiturates-vs-benzodiazepines/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.gratitudelodge.com/drug-info/vs/barbiturates-vs-benzodiazepines/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.gratitudelodge.com/drug-info/vs/barbiturates-vs-benzodiazepines/</a></span></div></li><li id="https://impactoutpatientprogram.com/barbiturates-vs-benzodiazepines-an-in-depth-look-at-their-effects-and-risks/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://impactoutpatientprogram.com/barbiturates-vs-benzodiazepines-an-in-depth-look-at-their-effects-and-risks/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://impactoutpatientprogram.com/barbiturates-vs-benzodiazepines-an-in-depth-look-at-their-effects-and-risks/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7912725/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7912725/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7912725/</a></span></div></li><li id="https://psyclarityhealth.com/benzodiazepines-vs-barbiturates-for-anxiety-treatment/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://psyclarityhealth.com/benzodiazepines-vs-barbiturates-for-anxiety-treatment/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://psyclarityhealth.com/benzodiazepines-vs-barbiturates-for-anxiety-treatment/</a></span></div></li><li id="https://arkviewbh.com/rehab-blog/barbiturates-vs-benzodiazepines/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://arkviewbh.com/rehab-blog/barbiturates-vs-benzodiazepines/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://arkviewbh.com/rehab-blog/barbiturates-vs-benzodiazepines/</a></span></div></li><li id="https://www.thefreedomcenter.com/barbiturates-vs-benzodiazepines/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thefreedomcenter.com/barbiturates-vs-benzodiazepines/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thefreedomcenter.com/barbiturates-vs-benzodiazepines/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3375401/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3375401/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3375401/</a></span></div></li><li id="http://www.acnp.org/g4/GN401000173/CH169.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="http://www.acnp.org/g4/GN401000173/CH169.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">http://www.acnp.org/g4/GN401000173/CH169.html</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/29763050/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/29763050/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/29763050/</a></span></div></li><li id="https://www.mcgill.ca/oss/article/drugs-history-you-asked/what-truth-serum" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mcgill.ca/oss/article/drugs-history-you-asked/what-truth-serum" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mcgill.ca/oss/article/drugs-history-you-asked/what-truth-serum</a></span></div></li><li id="https://www.businessinsider.com/is-there-such-a-thing-as-truth-serum-2014-10" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.businessinsider.com/is-there-such-a-thing-as-truth-serum-2014-10" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.businessinsider.com/is-there-such-a-thing-as-truth-serum-2014-10</a></span></div></li><li id="https://www.cia.gov/resources/csi/static/Truth-Drugs-in-Interrogation.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cia.gov/resources/csi/static/Truth-Drugs-in-Interrogation.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cia.gov/resources/csi/static/Truth-Drugs-in-Interrogation.pdf</a></span></div></li><li id="https://onwisconsin.uwalumni.com/the-chemistry-of-truthfulness/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://onwisconsin.uwalumni.com/the-chemistry-of-truthfulness/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://onwisconsin.uwalumni.com/the-chemistry-of-truthfulness/</a></span></div></li><li id="https://www.bbc.com/news/magazine-24371140" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.bbc.com/news/magazine-24371140" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.bbc.com/news/magazine-24371140</a></span></div></li><li id="https://www.sciencehistory.org/stories/magazine/stranger-than-fiction/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencehistory.org/stories/magazine/stranger-than-fiction/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencehistory.org/stories/magazine/stranger-than-fiction/</a></span></div></li><li id="https://scholarlycommons.law.northwestern.edu/cgi/viewcontent.cgi?article=5056&amp;context=jclc" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://scholarlycommons.law.northwestern.edu/cgi/viewcontent.cgi?article=5056&amp;context=jclc" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://scholarlycommons.law.northwestern.edu/cgi/viewcontent.cgi?article=5056&amp;context=jclc</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2900002/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2900002/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2900002/</a></span></div></li><li id="https://www.intelligence.senate.gov/wp-content/uploads/2024/08/sites-default-files-hearings-95mkultra.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.intelligence.senate.gov/wp-content/uploads/2024/08/sites-default-files-hearings-95mkultra.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.intelligence.senate.gov/wp-content/uploads/2024/08/sites-default-files-hearings-95mkultra.pdf</a></span></div></li><li id="https://www.medscape.com/viewarticle/742070_3" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.medscape.com/viewarticle/742070_3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.medscape.com/viewarticle/742070_3</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC5824315/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5824315/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC5824315/</a></span></div></li><li id="https://www.bbc.com/news/health-19989167" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.bbc.com/news/health-19989167" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.bbc.com/news/health-19989167</a></span></div></li><li id="https://www.jpsmjournal.com/article/S0885-3924%2818%2930339-7/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jpsmjournal.com/article/S0885-3924%2818%2930339-7/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jpsmjournal.com/article/S0885-3924%2818%2930339-7/fulltext</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6314932/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6314932/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6314932/</a></span></div></li><li id="https://www.npr.org/2019/07/26/745722219/lethal-injection-drugs-efficacy-and-availability-for-federal-executions" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.npr.org/2019/07/26/745722219/lethal-injection-drugs-efficacy-and-availability-for-federal-executions" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.npr.org/2019/07/26/745722219/lethal-injection-drugs-efficacy-and-availability-for-federal-executions</a></span></div></li><li id="https://time.com/5636513/pentobarbital-executions-justice-department/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://time.com/5636513/pentobarbital-executions-justice-department/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://time.com/5636513/pentobarbital-executions-justice-department/</a></span></div></li><li id="https://www.bmj.com/content/366/bmj.l4918" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.bmj.com/content/366/bmj.l4918" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.bmj.com/content/366/bmj.l4918</a></span></div></li><li id="https://www.npr.org/2024/07/10/g-s1-9016/unmarked-cars-and-secret-orders-how-a-pharmacy-prepared-drugs-for-texas-executions" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.npr.org/2024/07/10/g-s1-9016/unmarked-cars-and-secret-orders-how-a-pharmacy-prepared-drugs-for-texas-executions" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.npr.org/2024/07/10/g-s1-9016/unmarked-cars-and-secret-orders-how-a-pharmacy-prepared-drugs-for-texas-executions</a></span></div></li><li id="https://deathpenaltyinfo.org/executions/methods-of-execution/lethal-injection/compounding-pharmacies" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://deathpenaltyinfo.org/executions/methods-of-execution/lethal-injection/compounding-pharmacies" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://deathpenaltyinfo.org/executions/methods-of-execution/lethal-injection/compounding-pharmacies</a></span></div></li><li id="https://indianacapitalchronicle.com/2024/07/05/what-is-pentobarbital-more-questions-than-answers-around-indianas-new-execution-drug/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://indianacapitalchronicle.com/2024/07/05/what-is-pentobarbital-more-questions-than-answers-around-indianas-new-execution-drug/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://indianacapitalchronicle.com/2024/07/05/what-is-pentobarbital-more-questions-than-answers-around-indianas-new-execution-drug/</a></span></div></li><li id="https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf</a></span></div></li><li id="https://www.dea.gov/factsheets/barbiturates" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.dea.gov/factsheets/barbiturates" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.dea.gov/factsheets/barbiturates</a></span></div></li><li id="https://www.regulations.gov/document/DEA-2022-0027-0001" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.regulations.gov/document/DEA-2022-0027-0001" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.regulations.gov/document/DEA-2022-0027-0001</a></span></div></li><li id="https://www.dea.gov/drug-information/drug-scheduling" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.dea.gov/drug-information/drug-scheduling" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.dea.gov/drug-information/drug-scheduling</a></span></div></li><li id="https://www.who.int/groups/ecdd/about-us/substance-control-ecosystem" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.who.int/groups/ecdd/about-us/substance-control-ecosystem" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.who.int/groups/ecdd/about-us/substance-control-ecosystem</a></span></div></li><li id="https://www.incb.org/incb/en/news/news_2021/50-years-of-international-control-in-psychotropic-substances.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.incb.org/incb/en/news/news_2021/50-years-of-international-control-in-psychotropic-substances.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.incb.org/incb/en/news/news_2021/50-years-of-international-control-in-psychotropic-substances.html</a></span></div></li><li id="https://www.gov.uk/government/publications/controlled-drugs-list--2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.gov.uk/government/publications/controlled-drugs-list--2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.gov.uk/government/publications/controlled-drugs-list--2</a></span></div></li><li id="https://www.drugwise.org.uk/what-are-the-uk-drug-laws/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.drugwise.org.uk/what-are-the-uk-drug-laws/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.drugwise.org.uk/what-are-the-uk-drug-laws/</a></span></div></li><li id="https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/controlled-substances/compliance-monitoring/travelling-into-and-out-of-canada-with-prescription-medication-containing-controlled-substances.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/controlled-substances/compliance-monitoring/travelling-into-and-out-of-canada-with-prescription-medication-containing-controlled-substances.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/controlled-substances/compliance-monitoring/travelling-into-and-out-of-canada-with-prescription-medication-containing-controlled-substances.html</a></span></div></li><li id="https://www.unodc.org/pdf/convention_1971_en.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.unodc.org/pdf/convention_1971_en.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.unodc.org/pdf/convention_1971_en.pdf</a></span></div></li><li id="https://www.sciencedirect.com/topics/medicine-and-dentistry/barbital" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/barbital" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/topics/medicine-and-dentistry/barbital</a></span></div></li><li id="https://www.therecoveryvillage.com/barbiturate-addiction/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.therecoveryvillage.com/barbiturate-addiction/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.therecoveryvillage.com/barbiturate-addiction/</a></span></div></li><li id="https://www.news-medical.net/health/Barbiturate-Abuse.aspx" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.news-medical.net/health/Barbiturate-Abuse.aspx" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.news-medical.net/health/Barbiturate-Abuse.aspx</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2495124/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2495124/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2495124/</a></span></div></li><li id="https://www.govinfo.gov/content/pkg/CPRT-92SPRT87006/pdf/CPRT-92SPRT87006.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.govinfo.gov/content/pkg/CPRT-92SPRT87006/pdf/CPRT-92SPRT87006.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.govinfo.gov/content/pkg/CPRT-92SPRT87006/pdf/CPRT-92SPRT87006.pdf</a></span></div></li><li id="https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/what-scope-prescription-drug-misuse" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/what-scope-prescription-drug-misuse" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/what-scope-prescription-drug-misuse</a></span></div></li><li id="https://www.lakeviewbehavioralhealth.com/addiction/barbiturates/effects-signs-symptoms/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.lakeviewbehavioralhealth.com/addiction/barbiturates/effects-signs-symptoms/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.lakeviewbehavioralhealth.com/addiction/barbiturates/effects-signs-symptoms/</a></span></div></li><li id="https://www.healthcare.uiowa.edu/path_handbook/lab_bulletins/archived/2010/DrugOfAbuseUpdate.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.healthcare.uiowa.edu/path_handbook/lab_bulletins/archived/2010/DrugOfAbuseUpdate.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.healthcare.uiowa.edu/path_handbook/lab_bulletins/archived/2010/DrugOfAbuseUpdate.html</a></span></div></li><li id="https://drugabuse.com/drugs/barbiturates/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://drugabuse.com/drugs/barbiturates/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://drugabuse.com/drugs/barbiturates/</a></span></div></li></ol></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm" id="_R_" async=""></script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\"}]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"Barbiturate\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"Barbiturate\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"Barbiturate\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"21:I[6367,[],\"IconMark\"]\n1f:Tfee5,"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"# Barbiturate\n\n![Barbituric acid structure](./_assets_/Barbituric-acid-structural.svg.png)\n\nBarbiturates are a class of sedative-hypnotic drugs derived from barbituric acid, which act as central nervous system depressants by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at GABA_A receptors, leading to sedation, hypnosis, and anticonvulsant properties.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/) First synthesized in 1864 by Adolf von Baeyer, though barbituric acid itself lacks pharmacological activity, the class gained clinical prominence in the early 1900s with the introduction of barbital, revolutionizing treatment for insomnia, anxiety, epilepsy, and as anesthetics.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC1079678/)\n\nDespite their efficacy, barbiturates exhibit a narrow therapeutic index, where the dose for therapeutic effect closely approaches that causing respiratory depression, coma, and death, compounded by rapid tolerance development and high abuse liability that fosters physical dependence.[](https://pubmed.ncbi.nlm.nih.gov/9255991/)[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) This has led to their replacement in most indications by benzodiazepines and other agents with wider safety margins, restricting modern use primarily to refractory status epilepticus, certain neonatal conditions, and veterinary euthanasia.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)[](https://www.ncbi.nlm.nih.gov/books/NBK499875/) Historical overprescription contributed to widespread iatrogenic addiction and overdose epidemics, underscoring the causal link between their pharmacological profile and public health risks.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/)\n\n## Chemical Structure and Classification\n\n### Derivatives of Barbituric Acid\n\n![Barbituric acid structure](./_assets_/Barbituric-acid-structural.svg.png)\nBarbiturates constitute a class of sedative-hypnotic drugs obtained by modifying barbituric acid, the parent compound chemically known as pyrimidine-2,4,6(1H,3H,5H)-trione, which itself exhibits no central nervous system depressant effects.[](https://pubchem.ncbi.nlm.nih.gov/compound/Barbituric-Acid)[](https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/barbituric-acid) The key structural alteration involves disubstitution at the 5-position of the barbituric acid ring with alkyl, aryl, or other lipophilic groups, such as ethyl and phenyl in phenobarbital (5-ethyl-5-phenylbarbituric acid) or ethyl and 1-methylbutyl in pentobarbital.[](https://www.pharmacy180.com/article/barbiturates-2101/)[](https://www.euda.europa.eu/publications/drug-profiles/barbiturates_en) This modification enhances lipid solubility and enables binding to GABA_A receptors, conferring pharmacological activity.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)\n\nSynthesis of these derivatives typically proceeds via condensation of diethyl malonate derivativesâ€”alkylated at the alpha positionâ€”with urea or thiourea under basic conditions, followed by cyclization and hydrolysis.[](https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_%28OpenStax%29/22%253A_Carbonyl_Alpha-Substitution_Reactions/22.08%253A_Chemistry_MattersBarbiturates) More than 2,500 such compounds have been synthesized since the early 20th century, with variations in substituents influencing potency, duration of action, and solubility; for instance, dialkyl substitutions like in barbital (5,5-diethylbarbituric acid) yield longer-acting agents, while aryl-alkyl combinations produce intermediate effects.[](https://chem.libretexts.org/Bookshelves/Biological_Chemistry/Supplemental_Modules_%28Biological_Chemistry%29/Pharmaceuticals/Barbiturates_and_Benzodiazepines)[](https://www.pharmacy180.com/article/barbiturates-2101/)\n\nFurther derivatization includes replacement of the 2-position oxygen with sulfur, forming thiobarbiturates such as thiopental (5-ethyl-5-(1-methylbutyl)-2-thiobarbituric acid), which exhibit greater lipophilicity, rapid onset, and ultrashort duration due to redistribution from the brain.[](https://accessanesthesiology.mhmedical.com/content.aspx?sectionid=61587846\u0026bookid=974) Approximately 50 barbiturate derivatives have entered clinical use, including phenobarbital (introduced 1912), pentobarbital, and secobarbital, though many were later restricted due to safety profiles.[](https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/barbituric-acid)[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) These structural insights underpin classifications by duration, with short-acting agents favoring branched alkyl chains at C-5 for quicker metabolism.[](https://chem.libretexts.org/Bookshelves/Biological_Chemistry/Supplemental_Modules_%28Biological_Chemistry%29/Pharmaceuticals/Barbiturates_and_Benzodiazepines)\n\n### Duration-Based Classification\n\nBarbiturates are classified based on the duration of their sedative-hypnotic effects, which correlates with their lipid solubility and rate of redistribution from the brain to peripheral tissues, influencing onset, peak action, and termination of effect independent of hepatic metabolism in many cases.[](https://accessemergencymedicine.mhmedical.com/content.aspx?bookid=2353\u0026sectionid=220744425) This system divides them into ultra-short-acting, short-acting, intermediate-acting, and long-acting categories, guiding clinical applications from rapid anesthesia induction to chronic seizure control.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)\n\nUltra-short-acting barbiturates exhibit effects lasting approximately 5 to 30 minutes following intravenous administration, primarily due to rapid redistribution into less vascularized tissues.[](https://my.clevelandclinic.org/health/treatments/23271-barbiturates) Examples include thiopental (also known as thiopentone), which has an onset of 10 to 30 seconds and a hypnotic duration of 5 to 10 minutes, and methohexital, with similar pharmacokinetics suited for brief procedures.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) These agents are almost exclusively reserved for anesthesia induction owing to their fleeting action.[](https://www.sciencedirect.com/topics/medicine-and-dentistry/barbiturate)\n\nShort-acting barbiturates produce hypnosis for 2 to 6 hours, with oral onset in 15 to 30 minutes and peak effects within 1 to 2 hours.[](https://my.clevelandclinic.org/health/treatments/23271-barbiturates) Representative compounds are pentobarbital (Nembutal), featuring a half-life of 15 to 50 hours but shorter hypnotic duration due to redistribution, and secobarbital (Seconal), often used historically for preoperative sedation or short-term insomnia treatment.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)[](https://www.drugs.com/drug-class/barbiturates.html)\n\nIntermediate-acting barbiturates have durations of 3 to 8 hours, balancing sedation needs for procedures or sleep without excessive hangover effects.[](https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/barbiturate) Amobarbital (Amytal) exemplifies this group, with hypnotic effects lasting 4 to 6 hours after oral dosing, while butalbital, typically combined in formulations for tension headaches, shares comparable kinetics.[](https://my.clevelandclinic.org/health/treatments/23271-barbiturates)\n\nLong-acting barbiturates sustain effects for 6 to 12 hours or longer, often extending to 24 hours or more for hypnotic purposes, owing to slower redistribution and reliance on metabolic elimination.[](https://www.sciencedirect.com/topics/medicine-and-dentistry/barbiturate) Phenobarbital (Luminal), with a half-life of 37 to 140 hours, is the prototypical agent, employed for epilepsy management due to its prolonged anticonvulsant activity despite accumulation risks.[](https://www.drugs.com/drug-class/barbiturates.html)[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)\n\n| Category              | Approximate Hypnotic Duration | Key Examples                  |\n|-----------------------|-------------------------------|-------------------------------|\n| Ultra-short-acting   | 5â€“30 minutes                 | Thiopental, methohexital     |\n| Short-acting         | 2â€“6 hours                    | Pentobarbital, secobarbital  |\n| Intermediate-acting  | 3â€“8 hours                    | Amobarbital, butalbital      |\n| Long-acting          | 6â€“12+ hours                  | Phenobarbital                |\n\nThis table summarizes typical durations derived from clinical pharmacology data, though individual variability arises from dose, route, and patient factors such as age or liver function.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)[](https://my.clevelandclinic.org/health/treatments/23271-barbiturates)\n\n## History\n\n### Discovery and Synthesis\n\n![Structure of barbituric acid](./_assets_/Barbituric-acid-structural.svg.png)\n\nBarbituric acid, the parent compound of barbiturates, was first synthesized on November 27, 1864, by German chemist Adolf von Baeyer through the condensation of urea and malonic acid.[](https://www.ch.ic.ac.uk/rzepa/mim/drugs/html/barbiturate.htm) The name derives from the fact that Baeyer prepared it on the feast day of Saint Barbara.[](https://www.general-anaesthesia.com/people/adolf-baeyer.html) Although barbituric acid itself exhibited no significant pharmacological activity, its structure provided a foundation for subsequent derivatization efforts aimed at exploring potential therapeutic applications.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/)\n\nThe synthesis process involved reacting urea with diethyl malonate under basic conditions, yielding the cyclic barbituric acid core characterized by two carbonyl groups adjacent to a nitrogen atom in a pyrimidine ring.[](https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/barbituric-acid) This method was later refined by French chemist Ã‰douard Grimaux in 1879, improving yields and purity for further chemical investigations into uric acid derivatives.[](https://www.news-medical.net/health/Barbiturate-History.aspx) Early work focused on structural elucidation rather than biological effects, as barbituric acid and initial analogs showed no hypnotic or sedative properties in preliminary tests.[](https://pubs.acs.org/doi/pdf/10.1021/ed028p524)\n\nBreakthrough in pharmacological utility occurred in 1903 when Emil Fischer, a Nobel laureate in chemistry and former collaborator of Baeyer, synthesized 5,5-diethylbarbituric acid (barbital).[](https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/barbituric-acid) Fischer patented the compound in January 1903, and pharmacologist Joseph von Mering demonstrated its potent hypnotic effects in animal models, particularly dogs, leading to its introduction as Veronal, the first clinically viable barbiturate sedative.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/) This discovery marked the transition from purely synthetic curiosity to therapeutic agent, with barbital's diethyl substitution at the 5-position of the barbituric acid ring conferring central nervous system depression.[](https://pubsapp.acs.org/cen/coverstory/83/8325/8325phenobarbital.html) Subsequent alkylations and variations on this scaffold enabled the rapid proliferation of barbiturate derivatives.[](https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_%28OpenStax%29/22%253A_Carbonyl_Alpha-Substitution_Reactions/22.08%253A_Chemistry_MattersBarbiturates)\n\n### Medical Adoption and Expansion\n\nThe first barbiturate adopted for clinical use was barbital (also known as Veronal), whose sedative and hypnotic properties were identified in 1903 by researchers Josef von Mering and Emil Fischer; it was introduced commercially by Bayer in 1904 as a treatment for insomnia and nervousness, offering a safer alternative to existing agents like bromides.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/) This marked the initial medical adoption, with barbital rapidly gaining acceptance for its reliability in inducing sleep without the toxicity issues of prior sedatives.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/)\n\nThe success of barbital spurred extensive research and synthesis efforts, leading to the development of phenobarbital (Luminal) in 1911 by Heinrich HÃ¶rlein at Bayer, which was marketed in 1912 primarily for sedation but quickly established as an effective anticonvulsant for epilepsy after Alfred Hauptmann demonstrated its ability to suppress seizures without excessive drowsiness.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/)[](https://pubmed.ncbi.nlm.nih.gov/23205960/) By the 1920s, pharmaceutical companies such as Eli Lilly and Abbott Laboratories accelerated expansion through new derivatives, including amobarbital (Amytal) in 1923 for sedation, secobarbital (Seconal) in 1929, and pentobarbital (Nembutal) in 1930 for both sedation and epilepsy management.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/)\n\nFurther innovation in the 1930s extended barbiturate applications to anesthesia, exemplified by thiopental (Pentothal) introduced by Abbott in 1935, which enabled rapid intravenous induction and revolutionized surgical procedures by allowing shorter-acting, controllable sedation compared to inhalational agents.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/) Over the early to mid-20th century, more than 2,500 barbiturates were synthesized, with approximately 50 achieving clinical use, dominating therapeutic categories such as anxiolytics, hypnotics, and pre-anesthetic medications from the 1920s until the mid-1950s, when they comprised nearly all available options for these indications.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/) This proliferation reflected their perceived efficacy and versatility in addressing central nervous system disorders, though later scrutiny revealed limitations in safety margins.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/)\n\n### Decline Due to Safety Concerns\n\nThe widespread use of barbiturates began to decline in the mid-20th century primarily due to their narrow therapeutic index, which made accidental and intentional overdoses highly lethal; doses producing sedation could readily escalate to respiratory depression, coma, and death without a clear safety margin.[](https://www.ncbi.nlm.nih.gov/books/NBK499875/) Unlike safer alternatives, barbiturates lacked a ceiling effect on CNS depression, leading to frequent fatalitiesâ€”by the 1950s and 1960s, they were implicated in a significant proportion of drug-related suicides and accidental poisonings, with postmortem data showing barbiturates in up to 20-30% of such cases in some Western countries.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/) Dependence developed rapidly with chronic use, characterized by tolerance requiring escalating doses and severe withdrawal symptoms including seizures and delirium, further eroding their favorability for long-term therapy.[](https://emedicine.medscape.com/article/813155-overview)\n\nThe introduction of benzodiazepines marked a pivotal shift, as these agents offered anxiolytic and hypnotic effects with markedly lower risks of fatal overdose and dependence; chlordiazepoxide (Librium) was approved by the FDA in 1960, followed by diazepam (Valium) in 1963, rapidly supplanting barbiturates for treating anxiety, insomnia, and seizures due to their wider safety profile and reduced respiratory suppression even at high doses.[](https://my.clevelandclinic.org/health/treatments/24570-benzodiazepines-benzos) By the late 1960s, clinical guidelines increasingly recommended benzodiazepines over barbiturates, contributing to a steep drop in barbiturate prescriptionsâ€”U.S. data indicate a decline from peak usage in the 1950s to less than 10% of sedative prescriptions by the 1980s.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/)\n\nRegulatory responses amplified this decline amid rising abuse concerns; the U.S. Controlled Substances Act of 1970 classified most barbiturates as Schedule II (high abuse potential) or III drugs, imposing strict prescribing limits and monitoring, while similar controls emerged in Europe following reports of widespread misuse in the 1960s counterculture era.[](https://emedicine.medscape.com/article/813155-overview) These measures, coupled with accumulating evidence of barbiturate-related hospital admissions for toxicityâ€”often involving synergistic effects with alcoholâ€”solidified their relegation to niche roles like refractory epilepsy and anesthesia induction, where their potency remains unmatched but risks are managed in controlled settings.[](https://www.ncbi.nlm.nih.gov/books/NBK499875/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/)\n\n## Pharmacology\n\n### Mechanism of Action\n\nBarbiturates exert their central nervous system depressant effects primarily through positive allosteric modulation of Î³-aminobutyric acid type A (GABA_A) receptors, the predominant inhibitory receptors in the brain.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) These receptors are ligand-gated chloride channels composed of multiple subunits, including Î±, Î², and Î³ isoforms. Barbiturates bind to a site distinct from the orthosteric GABA-binding pocket, typically involving interactions with the Î± and Î² subunits in the transmembrane domain, which enhances GABA's affinity and efficacy.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) [](https://go.drugbank.com/drugs/DB01341) This modulation prolongs the duration of chloride channel opening triggered by GABA, increasing chloride influx into postsynaptic neurons, which hyperpolarizes the membrane and suppresses neuronal excitability and firing.[](https://pubmed.ncbi.nlm.nih.gov/23205959/) Unlike benzodiazepines, which primarily increase the frequency of channel opening, barbiturates' prolongation of open time contributes to their greater potency in inducing sedation, hypnosis, and anesthesia.[](https://pubmed.ncbi.nlm.nih.gov/23205959/)\n\nAt higher concentrations, corresponding to anesthetic or anticonvulsant doses, barbiturates can directly activate GABA_A receptors independently of GABA, further augmenting chloride conductance and inhibitory tone.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) [](https://pubmed.ncbi.nlm.nih.gov/23205959/) This direct gating is evident in studies using recombinant receptors and neuronal cultures, where compounds like pentobarbital elicit chloride currents without agonist presence, distinguishing barbiturates from weaker modulators.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC1161000/) The Î² subunit's second and third transmembrane domains, including specific methionine residues, are critical for this barbiturate sensitivity, as demonstrated in mutagenesis experiments.[](https://pubmed.ncbi.nlm.nih.gov/23205959/)\n\nSecondary mechanisms include antagonism of excitatory glutamate receptors, such as AMPA/kainate subtypes, and inhibition of glutamate release via presynaptic P/Q-type voltage-gated calcium channels, which reduce excitatory neurotransmission and reinforce overall CNS depression.[](https://pubmed.ncbi.nlm.nih.gov/23205959/) [](https://go.drugbank.com/drugs/DB01341) However, GABA_A modulation remains the dominant pathway, with potency varying by barbiturate structure and receptor subunit composition; for instance, phenobarbital shows less direct activation than pentobarbital, correlating with differential sedative profiles.[](https://pubmed.ncbi.nlm.nih.gov/23205959/)\n\n### Pharmacokinetics and Metabolism\n\nBarbiturates exhibit variable pharmacokinetics depending on their chemical structure and lipophilicity, influencing their absorption, distribution, metabolism, and excretion. Most are well-absorbed orally, with phenobarbital achieving peak plasma concentrations in 2 to 4 hours and approximately 90% bioavailability in adults, though neonates show reduced bioavailability.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) Intravenous administration provides rapid onset for applications like status epilepticus or anesthesia, while rectal or intramuscular routes offer alternatives with varying absorption rates.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)\n\nDistribution is characterized by high lipid solubility, enabling rapid crossing of the blood-brain barrier and extensive tissue penetration, including into the central nervous system.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) Highly lipophilic agents like thiopental and methohexital undergo quick redistribution from brain to peripheral tissues such as muscle and fat, which primarily terminates their ultra-short hypnotic effects after moderate doses (e.g., 5 mg/kg for thiopental), rather than relying on metabolism.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)[](https://www.sciencedirect.com/science/article/pii/S0261988121001907) Larger doses prolong action by saturating redistribution sites, shifting dependence toward slower elimination processes.[](https://www.sciencedirect.com/science/article/pii/S0261988121001907) Plasma protein binding varies, affecting free drug levels available for pharmacological action.\n\nMetabolism occurs predominantly in the liver through oxidation via cytochrome P450 enzymes, converting lipophilic barbiturates into inactive, water-soluble metabolites.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) Phenobarbital, a long-acting barbiturate, undergoes extensive hepatic biotransformation and potently induces CYP1A2, CYP2B6, CYP2C9, and CYP3A4/5 enzymes, accelerating its own clearance (autoinduction) and that of co-administered drugs, which contributes to tolerance development as half-life shortens by approximately 4.6 hours per day with chronic use.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) Shorter-acting barbiturates like secobarbital follow similar pathways but with faster rates, while ultra-short agents like thiopental exhibit first-order kinetics at low doses but non-linear elimination at higher doses due to saturation.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) Primidone, a barbiturate precursor, is metabolized to phenobarbital and phenylethylmalonamide.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)\n\nExcretion is primarily renal, with most barbiturates eliminated as metabolites in urine; phenobarbital is unique in that about 25% is excreted unchanged, a process enhanced by urinary alkalinization or osmotic diuresis to ionize the weakly acidic drug and prevent tubular reabsorption.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) Elimination rates are faster in younger individuals and slower in the elderly, infants, or those with hepatic impairment, influencing dosing adjustments.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) For thiopental and methohexital, metabolism and excretion play secondary roles to redistribution in determining clinical duration, with methohexital cleared about three times faster than thiopental, reducing accumulation risks.[](https://www.sciencedirect.com/science/article/pii/S0261988121001907) These pharmacokinetic properties underpin the classification of barbiturates by duration of actionâ€”ultra-short (e.g., thiopental, 3-8 minutes hypnotic effect), short-to-intermediate (e.g., secobarbital, 15-40 hours half-life), and long (e.g., phenobarbital, 53-118 hours initially)â€”and explain their potential for drug interactions via enzyme induction.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)[](https://www.sciencedirect.com/science/article/pii/S0261988121001907)\n\n## Therapeutic Applications\n\n### Human Medical Uses\n\nBarbiturates are primarily employed in human medicine for their sedative-hypnotic and anticonvulsant properties, though their use has significantly diminished since the mid-20th century due to narrower therapeutic indices and the availability of safer alternatives like benzodiazepines.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) Specific indications include seizure management, where long-acting agents such as phenobarbital remain a first-line option for controlling generalized tonic-clonic seizures and status epilepticus, particularly in neonates and resource-limited settings.[](https://medlineplus.gov/druginfo/meds/a682007.html) [](https://www.ncbi.nlm.nih.gov/books/NBK532277/) In 2022, the U.S. Food and Drug Administration approved phenobarbital sodium (Sezaby) specifically for treating neonatal seizures in term and preterm infants, highlighting its role in pediatric neurology when other therapies fail.[](https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215910s000lbl.pdf)\n\nFor anesthesia, ultra-short-acting barbiturates like thiopental (pentothal) are used intravenously to induce rapid unconsciousness, typically within 30-45 seconds, in surgical procedures requiring quick onset, though propofol has largely supplanted them in routine practice.[](https://my.clevelandclinic.org/health/treatments/23271-barbiturates) [](https://accessanesthesiology.mhmedical.com/content.aspx?sectionid=61587846\u0026bookid=974) Preoperative sedation and anxiety relief also utilize intermediate-acting barbiturates such as butabarbital, administered orally or rectally to calm patients prior to surgery, but only short-term to minimize dependence risks.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) [](https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/000793s026lbl.pdf)\n\nIn neonatal care, barbiturates address withdrawal syndromes from intrauterine opioid exposure, with phenobarbital titrated to suppress symptoms like irritability and tremors, often at doses of 3-5 mg/kg/day divided every 12 hours.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) Limited applications persist for refractory insomnia unresponsive to non-pharmacologic interventions or safer hypnotics, where short-acting forms like secobarbital may be prescribed cautiously for 1-2 weeks.[](https://www.news-medical.net/health/What-are-Barbiturates.aspx) Phenobarbital occasionally serves as an adjunct for benzodiazepine withdrawal, leveraging its long half-life (approximately 53-118 hours in adults) to taper dependence gradually.[](https://www.drugs.com/mtm/phenobarbital.html) Overall, contemporary guidelines from bodies like the American Academy of Neurology recommend barbiturates primarily for epilepsy in developing regions or when cost and enzyme-inducing effects (e.g., for metabolizing other anticonvulsants) are advantageous.[](https://www.epilepsy.com/tools-resources/seizure-medication-list/phenobarbital)\n\n### Veterinary and Procedural Uses\n\nIn veterinary medicine, phenobarbital serves as a primary anticonvulsant for managing idiopathic epilepsy and other seizure disorders in dogs and cats, with typical oral dosages of 2-4 mg/kg twice daily achieving therapeutic serum levels of 15-45 Î¼g/mL to suppress seizure activity.[](https://veterinarypartner.vin.com/doc/?id=4951404\u0026pid=19239)[](https://www.petmd.com/pet-medication/phenobarbital-dogs-and-cats) The U.S. Food and Drug Administration conditionally approved phenobarbital tablets (Fidoquel-CA1) on September 6, 2023, specifically for controlling seizures associated with idiopathic epilepsy in dogs, reflecting its established efficacy despite potential side effects like sedation, ataxia, and hepatotoxicity requiring periodic monitoring.[](https://www.fda.gov/animal-veterinary/cvm-updates/fda-conditionally-approves-phenobarbital-tablets-control-seizures-dogs-idiopathic-epilepsy) In cats, once-daily dosing has demonstrated 88% seizure remission rates without notable compliance issues or adverse effects in controlled studies.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10812035/)\n\nSodium pentobarbital, often combined with phenytoin sodium (e.g., in products like Euthasol), remains the standard agent for humane euthanasia in small animals such as dogs and cats, administered intravenously at doses of 1 mL per 4.5 kg to induce rapid unconsciousness and cardiac arrest within seconds.[](https://www.vet.cornell.edu/facts-about-euthanasia-small-animals)[](https://vet-us.virbac.com/home/products/in-clinic-use/euthasol-pentobarbital-sodium-an.html) This method is endorsed by the American Veterinary Medical Association for its reliability and minimal pain, though it poses environmental risks, including secondary poisoning of scavengers like bald eagles via residue in euthanized carcasses, prompting FDA warnings since 2003 and guidelines for proper disposal to prevent tissue rendering.[](https://pubs.usgs.gov/publication/2001158)[](https://www.fws.gov/story/help-prevent-euthanasia-drugs-killing-bald-eagles-and-other-wildlife) Shortages, as occurred in 2021-2022, have necessitated alternatives like intracardiac or intraperitoneal injection in moribund animals, but intravenous pentobarbital is preferred for its speed and humane profile across species including horses, where brain activity flattens within 10 seconds.[](https://www.avma.org/blog/pentobarbital-back-orders-and-potential-alternatives)[](https://compneuro.vetmed.ucdavis.edu/research/humane-euthanasia)\n\nFor procedural sedation and anesthesia induction, ultra-short-acting barbiturates like thiopental are employed in veterinary practice to facilitate rapid onset for short, non-painful interventions or general anesthesia setup, with intravenous doses of 4-8 mg/kg in dogs and cats producing unconsciousness in under 30 seconds but requiring caution in lean breeds due to fat redistribution prolonging recovery.[](https://www.petplace.com/article/drug-library/drug-library/library/thiopental-pentothal-for-dogs-and-cats)[](https://veteriankey.com/injectable-anesthetic-agents/) However, their use has declined in favor of agents like propofol owing to cardiovascular depression, histamine release, and smoother recoveries, limiting current applications primarily to scenarios where alternatives are unavailable or contraindicated, such as in hypovolemic patients where effects are studied but not routinely recommended.[](https://wildernessvet.com/veterinary-anesthesia-demystified/)[](https://pubmed.ncbi.nlm.nih.gov/2053727/) In large animals, thiobarbiturates are occasionally combined with other agents for induction, though antithyroid effects in hyperthyroid patients warrant avoidance.[](https://www.westernu.edu/mediafiles/veterinary/vet-anesthesia-analgesia/pharmacology-intravenous-anesthetic-agents-dissociatives.pdf)\n\n## Risks and Adverse Effects\n\n### Acute Side Effects and Toxicity\n\nAcute side effects of barbiturates at therapeutic doses primarily involve central nervous system depression, manifesting as drowsiness, dizziness, ataxia, nystagmus, and slurred speech.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) These effects arise from the drugs' enhancement of GABA_A receptor activity, leading to neuronal hyperpolarization and reduced excitability across various brain regions.[](https://emedicine.medscape.com/article/813155-overview) Paradoxical excitation, such as agitation or hyperactivity, can occur particularly in elderly patients or children, though this is less common than sedative effects.[](https://www.ncbi.nlm.nih.gov/books/NBK499875/)\n\nToxicity emerges with doses exceeding therapeutic levels, due to barbiturates' narrow therapeutic index, where the margin between effective and lethal concentrations is smallâ€”exemplified by phenobarbital's range of 10-30 mg/L for efficacy versus higher levels causing severe impairment.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) [](https://emedicine.medscape.com/article/813155-overview) Initial toxic symptoms include profound sedation, impaired coordination, clouded mentation, and hypotension from vasodilation.[](https://www.ncbi.nlm.nih.gov/books/NBK499875/) As plasma concentrations rise, progression to coma, respiratory depression progressing to apnea, and cardiovascular instability ensues, with hypoventilation causing hypoxia and acidosis.[](https://medlineplus.gov/ency/article/000951.htm) [](https://www.ncbi.nlm.nih.gov/books/NBK499875/)\n\nSevere overdose, often intentional but also accidental given the drugs' pharmacokinetics allowing accumulation in adipose tissue, leads to multi-organ failure risks including renal impairment from hypotension and rhabdomyolysis.[](https://emedicine.medscape.com/article/813155-overview) Approximately 10% of barbiturate overdoses result in fatality, primarily from respiratory arrest or secondary complications like aspiration pneumonia.[](https://drugabuse.com/drugs/barbiturates/overdose/) Lethality is exacerbated by co-ingestion with alcohol or opioids, which synergistically depress respiration via shared GABAergic and mu-opioid pathways.[](https://my.clevelandclinic.org/health/treatments/23271-barbiturates) Barbiturates' zero-order elimination kinetics further heightens toxicity risk, as clearance becomes saturated, prolonging effects unpredictably.[](https://www.ncbi.nlm.nih.gov/books/NBK499875/)\n\n### Dependence, Tolerance, and Withdrawal\n\nBarbiturates induce tolerance through adaptive changes in the central nervous system, primarily involving downregulation of GABAA receptor sensitivity and alterations in chloride channel function, necessitating higher doses to achieve equivalent sedative or hypnotic effects.[](https://www.sciencedirect.com/science/article/pii/0024320596001993) This tolerance develops rapidly with regular use, often within days to weeks, particularly to the mood-altering and respiratory depressant effects, though anticonvulsant efficacy may persist longer.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)[](https://www.euda.europa.eu/publications/drug-profiles/barbiturates_en)\n\nPhysical dependence arises from prolonged exposure, even at therapeutic doses, as the body adapts to the drug's suppression of neuronal excitability, leading to a state where cessation disrupts homeostasis.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) Psychological dependence accompanies this, driven by reinforcement of anxiolytic effects, with risks escalating with duration and dosage; for instance, phenobarbital use beyond short-term indications frequently results in dependence requiring tapered discontinuation.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)[](https://addictionresource.com/drugs/barbiturates/dependence/)\n\nWithdrawal manifests 2 to 4 days after abrupt cessation in dependent individuals, progressing from mild autonomic hyperactivity to severe neurological symptoms including anxiety, tremor, nausea, insomnia, and potentially life-threatening seizures or delirium tremens-like states due to unchecked excitatory neurotransmission.[](https://pubmed.ncbi.nlm.nih.gov/10349206/)[](https://www.sciencedirect.com/science/article/abs/pii/S0006899304003737) The syndrome's severity correlates with prior dosage and chronicity, often exceeding that of benzodiazepines because of barbiturates' steeper dose-response curve and lack of ceiling effect on GABA enhancement, with mortality risks from status epilepticus or cardiovascular collapse if unmanaged.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC1268024/) Management typically involves gradual tapering with long-acting barbiturates or substitution with benzodiazepines under medical supervision to mitigate rebound hyperexcitability.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC1268024/)\n\n### Overdose Management and Lethality\n\nBarbiturates exhibit a narrow therapeutic index, with the margin between effective doses and those causing severe toxicity or death being particularly small, predisposing users to life-threatening overdose even at modestly supratherapeutic levels.[](https://www.ncbi.nlm.nih.gov/books/NBK499875/) Overdose primarily manifests through profound central nervous system depression, leading to coma, respiratory failure via hypoventilation and apnea, hypotension from myocardial depression and vasodilation, and potential cardiac arrhythmias; these effects are exacerbated by co-ingestion with alcohol, opioids, or benzodiazepines due to additive respiratory suppression.[](https://emedicine.medscape.com/article/813155-overview) The minimum lethal oral dose varies by compound and tolerance, typically ranging from 2-3 grams for short-acting agents like pentobarbital to 6-10 grams for long-acting phenobarbital in non-tolerant individuals, though chronic users may survive higher amounts due to developed tolerance.[](https://accessmedicine.mhmedical.com/content.aspx?bookid=2284\u0026sectionid=248383642) Case fatality rates in suicidal overdoses involving barbiturates have been reported as 5.8-12.2%, higher than for many other drug classes, reflecting their potent depressant effects.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7090840/) With modern supportive care, in-hospital mortality remains low at 0.5-2%, but untreated or delayed cases carry high lethality, particularly in the elderly or those with comorbidities like cardiovascular disease.[](https://www.ncbi.nlm.nih.gov/books/NBK499875/) [](https://emedicine.medscape.com/article/813155-overview)\n\nManagement of barbiturate overdose centers on supportive measures, as no specific antidote exists, unlike benzodiazepines which respond to flumazenil.[](https://www.ncbi.nlm.nih.gov/books/NBK499875/) Initial stabilization follows advanced trauma life support protocols, prioritizing airway protection via endotracheal intubation if Glasgow Coma Scale scores indicate risk of aspiration, mechanical ventilation for respiratory depression, and circulatory support with intravenous fluids or vasopressors for hypotension.[](https://emedicine.medscape.com/article/813155-treatment) Gastrointestinal decontamination with activated charcoal is recommended within 1-2 hours of ingestion to reduce absorption, particularly effective for long-acting barbiturates; multiple-dose regimens may further enhance elimination via enterohepatic recirculation.[](https://medlineplus.gov/ency/article/000951.htm) Patients require continuous monitoring of vital signs, electrocardiography for arrhythmias, and laboratory assessment of electrolytes, renal function, and drug levels, with alkaline diuresis historically used but now largely supplanted by extracorporeal methods.[](https://emedicine.medscape.com/article/813155-treatment)\n\nFor severe intoxications, especially with phenobarbital where half-life prolongation in overdose can extend coma to days, enhanced elimination techniques such as hemodialysis or hemoperfusion are indicated to accelerate clearance, reducing coma duration and complications like pneumonia or rhabdomyolysis. These interventions are prioritized in cases with levels exceeding 100 mcg/mL for phenobarbital or refractory hypotension, with evidence showing reduced mortality when applied early.[](https://www.uptodate.com/contents/barbiturate-phenobarbital-poisoning) Naloxone may be trialed if opioids are suspected as co-ingestants but lacks efficacy against pure barbiturate effects.[](https://americanaddictioncenters.org/barbiturate) Recovery typically involves intensive care observation until spontaneous ventilation resumes, with full neurological assessment to detect sequelae like persistent cognitive impairment.[](https://emedicine.medscape.com/article/813155-treatment)\n\n## Comparative Efficacy and Safety\n\n### Barbiturates Versus Benzodiazepines\n\nBarbiturates and benzodiazepines both potentiate the inhibitory effects of gamma-aminobutyric acid (GABA) at GABA_A receptors in the central nervous system, but differ in their binding sites and downstream effects. Barbiturates bind to a distinct site on the GABA_A receptor, prolonging the duration of chloride channel opening, which leads to deeper and more prolonged neuronal hyperpolarization.[](https://www.ardurecoverycenter.com/barbiturates-vs-benzodiazepines/) In contrast, benzodiazepines bind to a specific high-affinity site on the GABA_A receptor, increasing the frequency of channel opening without prolonging individual openings, resulting in less intense suppression of neuronal activity.[](https://www.ardurecoverycenter.com/barbiturates-vs-benzodiazepines/) This mechanistic distinction contributes to barbiturates' greater potency and broader suppression of central nervous system functions, including at non-GABAergic synapses.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)\n\nA primary clinical difference lies in their therapeutic indices and overdose risks. Barbiturates exhibit a narrow therapeutic index, where the dose required for therapeutic effect is close to the toxic dose, heightening the risk of respiratory depression, hypotension, and coma even at standard doses.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3684331/) Overdose with barbiturates frequently proves fatal due to profound respiratory arrest and cardiovascular collapse, with no effective reversal agent available beyond supportive care.[](https://www.ncbi.nlm.nih.gov/books/NBK499875/) Benzodiazepines, however, possess a wider therapeutic index, with lethal doses typically 100- to 500-fold higher than therapeutic ones, and rarely cause death when taken alone, though they can exacerbate risks when combined with other depressants like alcohol or opioids.[](https://www.tresvistasrecovery.com/services/outpatient-benzo-detox/barbiturates-vs-benzodiazepines/) Flumazenil serves as a specific antagonist for benzodiazepine overdose, enabling reversal in many cases.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)\n\n| Aspect                  | Barbiturates                                      | Benzodiazepines                                   |\n|-------------------------|---------------------------------------------------|---------------------------------------------------|\n| **Therapeutic Index**  | Narrow; high overdose lethality                  | Wide; lower fatal overdose risk alone             |\n| **Respiratory Depression** | Dose-dependent and profound, even at therapeutic levels | Milder; ceiling effect limits severity            |\n| **Dependence Potential**| High; rapid tolerance development                | High but slower onset; cross-tolerance possible   |\n| **Clinical Preference**| Limited to refractory seizures, anesthesia induction | First-line for anxiety, acute seizures, sedation  |\n\nIn terms of efficacy, benzodiazepines demonstrate comparable or superior anxiolytic, anticonvulsant, and sedative effects for most indications with reduced side effects, leading to their preferential use in anxiety disorders, insomnia, and procedural sedation since the 1960s.[](https://www.gratitudelodge.com/drug-info/vs/barbiturates-vs-benzodiazepines/) Barbiturates retain niche roles, such as in refractory status epilepticus or certain veterinary applications, where their deeper suppression proves necessary after benzodiazepine failure.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) Both classes induce tolerance and physical dependence with chronic use, but barbiturate withdrawal carries higher risks of seizures and delirium due to more severe rebound hyperexcitability.[](https://impactoutpatientprogram.com/barbiturates-vs-benzodiazepines-an-in-depth-look-at-their-effects-and-risks/) The replacement of barbiturates by benzodiazepines in routine medical practice stemmed from these safety advantages, reducing accidental deaths and improving outpatient manageability.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7912725/)[](https://www.gratitudelodge.com/drug-info/vs/barbiturates-vs-benzodiazepines/)\n\n### Reasons for Therapeutic Replacement\n\nBarbiturates have been progressively replaced in therapeutic applications by benzodiazepines and other sedative-hypnotics primarily due to their narrow therapeutic index, which is the ratio between the dose producing the desired effect and the dose causing toxicity. This narrow margin results in a small difference between effective sedative or anticonvulsant doses and those leading to severe respiratory depression or coma, elevating the risk of accidental or intentional overdose.[](https://psyclarityhealth.com/benzodiazepines-vs-barbiturates-for-anxiety-treatment/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3684331/)[](https://arkviewbh.com/rehab-blog/barbiturates-vs-benzodiazepines/)\n\nIn contrast, benzodiazepines exhibit a wider therapeutic index, allowing for safer administration with reduced likelihood of fatal outcomes even at higher doses, as they cause less profound suppression of respiratory drive. Barbiturates' mechanism of prolonging GABA_A receptor channel opening leads to maximal channel activation at high doses, lacking a ceiling effect that benzodiazepines possess, which contributes to their higher lethality in overdose scenarios.[](https://www.thefreedomcenter.com/barbiturates-vs-benzodiazepines/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3375401/)[](https://www.tresvistasrecovery.com/services/outpatient-benzo-detox/barbiturates-vs-benzodiazepines/)\n\nThe propensity for rapid tolerance, physical dependence, and severe withdrawal symptoms further diminished barbiturates' favorability, as chronic use necessitates escalating doses to maintain efficacy, heightening abuse potential and complicating discontinuation. Benzodiazepines, while not devoid of dependence risks, offer more manageable withdrawal profiles and antagonists like flumazenil for reversal, facilitating their preference in treating anxiety, insomnia, and procedural sedation.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)[](https://impactoutpatientprogram.com/barbiturates-vs-benzodiazepines-an-in-depth-look-at-their-effects-and-risks/)[](http://www.acnp.org/g4/GN401000173/CH169.html)\n\nThis shift accelerated in the mid-20th century following the introduction of benzodiazepines in the 1960s, with barbiturate prescriptions declining sharply over subsequent decades as clinical evidence highlighted their inferior safety relative to alternatives like non-benzodiazepine hypnotics for sleep disorders. Despite retained niche uses in refractory epilepsy or certain anesthetics, the overall therapeutic displacement reflects empirical prioritization of agents minimizing iatrogenic harm.[](https://pubmed.ncbi.nlm.nih.gov/29763050/)[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)[](https://emedicine.medscape.com/article/813155-overview)\n\n## Controversies and Societal Debates\n\n### Truth Serum Applications and Limitations\n\nBarbiturates such as sodium amytal (amobarbital) and sodium thiopental have been employed in so-called \"truth serum\" applications since the early 20th century, primarily to facilitate interrogations by reducing psychological inhibitions and inducing a hypnotic, confessional state.[](https://www.mcgill.ca/oss/article/drugs-history-you-asked/what-truth-serum) These drugs were administered intravenously to suspects or witnesses in psychiatric narcoanalysis sessions, with the aim of eliciting suppressed memories or admissions during states of sedation where critical faculties are impaired.[](https://www.businessinsider.com/is-there-such-a-thing-as-truth-serum-2014-10) Historical use peaked during World War II and the Cold War, including by U.S. military intelligence and the CIA's MKUltra program (1953â€“1973), which tested sodium thiopental among other agents for extracting information from prisoners or spies through chemical interrogation techniques.[](https://www.cia.gov/resources/csi/static/Truth-Drugs-in-Interrogation.pdf) Pioneering work by University of Wisconsin psychiatrist William Bleckwenn in the 1930s demonstrated sodium amytal's potential to break catatonic states in schizophrenia patients, leading to its extension into forensic contexts despite lacking empirical validation for veracity enhancement.[](https://onwisconsin.uwalumni.com/the-chemistry-of-truthfulness/)\n\nProponents claimed these barbiturates worked by depressing the central nervous system, lowering resistance to suggestion and promoting free association akin to hypnosis, as observed in clinical trials where subjects became unusually loquacious under dosages of 200â€“600 mg.[](https://www.bbc.com/news/magazine-24371140) In practice, applications extended to police investigations in the U.S. and Europe until the mid-20th century, with isolated cases like the 1922 use of scopolamine (a related alkaloid, later supplemented by barbiturates) in Texas criminal probes yielding purported confessions.[](https://www.sciencehistory.org/stories/magazine/stranger-than-fiction/) However, declassified CIA assessments from the 1950sâ€“1960s, including those under MKUltra Subproject 68, revealed inconsistent results, with drugs often producing rambling narratives rather than reliable disclosures.[](https://www.cia.gov/resources/csi/static/Truth-Drugs-in-Interrogation.pdf)\n\nDespite these applications, barbiturates do not function as genuine truth serums, as no pharmacological agent can compel veridical statements or override willful deception, according to evaluations by intelligence agencies and pharmacologists.[](https://www.cia.gov/resources/csi/static/Truth-Drugs-in-Interrogation.pdf) Subjects under influence exhibit heightened suggestibility, confabulation, and fantasy production, leading to fabricated details indistinguishable from facts; for instance, a 2013 experimental interrogation with sodium thiopental resulted in voluble but inaccurate responses from the subject.[](https://www.bbc.com/news/magazine-24371140) Scientific reviews confirm that while barbiturates disrupt executive function and inhibitory controlsâ€”via GABA receptor potentiationâ€”they fail to differentiate truth from falsehood, with error rates exceeding 50% in controlled tests due to residual cognitive biases and motivational lying.[](https://www.businessinsider.com/is-there-such-a-thing-as-truth-serum-2014-10) Courts worldwide, including U.S. federal rulings from the 1960s onward, deem such evidence inadmissible owing to unreliability and violation of due process, as affirmed in cases like *Townsend v. Sain* (1963).[](https://scholarlycommons.law.northwestern.edu/cgi/viewcontent.cgi?article=5056\u0026context=jclc)\n\nAdditional limitations include ethical prohibitions against non-consensual use, as outlined in psychiatric guidelines since the 1950s, and physiological risks such as respiratory depression or paradoxical excitation, which can terminate sessions prematurely or induce amnesia, further obscuring any potential insights.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2900002/) Post-MKUltra disclosures in 1977 Senate hearings highlighted abuses, including unwitting dosing leading to psychological harm, underscoring the causal disconnect between sedation and truth extraction.[](https://www.intelligence.senate.gov/wp-content/uploads/2024/08/sites-default-files-hearings-95mkultra.pdf) Modern consensus, informed by neuropharmacology, attributes any confessional effects to disinhibition rather than enhanced honesty, rendering barbiturates obsolete for interrogative purposes in favor of psychological and technological alternatives.[](https://www.mcgill.ca/oss/article/drugs-history-you-asked/what-truth-serum)\n\n### Role in Euthanasia, Assisted Suicide, and Capital Punishment\n\nBarbiturates, particularly pentobarbital and secobarbital, have been employed in jurisdictions permitting euthanasia and assisted suicide due to their capacity to induce rapid unconsciousness followed by respiratory arrest at high doses. In physician-assisted suicide under Oregon's Death with Dignity Act, eligible terminally ill patients receive prescriptions for secobarbital (typically 9-10 grams, equivalent to 90-100 capsules crushed and dissolved in liquid) or pentobarbital for self-administration, resulting in death within minutes to hours in the majority of cases reported annually since the law's enactment in 1997.[](https://www.medscape.com/viewarticle/742070_3) [](https://pmc.ncbi.nlm.nih.gov/articles/PMC5824315/) In Switzerland, organizations such as Dignitas facilitate assisted suicide by providing oral pentobarbital solutions (around 15 grams), which patients ingest to achieve coma and subsequent cardiorespiratory failure, with protocols established since the early 2000s.[](https://www.bbc.com/news/health-19989167) For active euthanasia in the Netherlands and Belgium, where physician administration is legal, barbiturates like pentobarbital (2-10 grams intravenously) are standard to first render the patient unconscious before additional agents ensure death, aligning with national guidelines emphasizing reliability and minimal distress.[](https://www.jpsmjournal.com/article/S0885-3924%2818%2930339-7/fulltext) These applications leverage barbiturates' pharmacological mechanism of enhancing GABA-mediated inhibition, leading to profound sedation and suppression of vital functions, though survival has occurred rarely from sublethal ingestions due to vomiting or incomplete absorption.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6314932/)\n\nIn capital punishment, barbiturates serve as the primary anesthetic in lethal injection protocols across U.S. states and federal executions, intended to ensure unconsciousness prior to cardiac arrest from subsequent drugs. Pentobarbital emerged as a single-drug alternative around 2010 amid shortages of sodium thiopental, with states like Texas administering 5 grams intravenously to condemned individuals, causing death via central nervous system and respiratory depression within 10-20 minutes when properly dosed.[](https://www.npr.org/2019/07/26/745722219/lethal-injection-drugs-efficacy-and-availability-for-federal-executions) The U.S. federal government adopted a one-drug pentobarbital protocol in 2019 for executions resumed after a 17-year hiatus, sourcing the compound domestically to bypass European export bans imposed since 2011 on drugs intended for lethal use.[](https://time.com/5636513/pentobarbital-executions-justice-department/) [](https://www.bmj.com/content/366/bmj.l4918) Compounding pharmacies have become key suppliers for states including Missouri and Texas, producing pentobarbital in unmarked facilities under secrecy laws to evade manufacturer refusals and legal challenges, with Texas procuring batches from local pharmacies like Rite-Away from 2019 through at least 2023.[](https://www.npr.org/2024/07/10/g-s1-9016/unmarked-cars-and-secret-orders-how-a-pharmacy-prepared-drugs-for-texas-executions) [](https://deathpenaltyinfo.org/executions/methods-of-execution/lethal-injection/compounding-pharmacies) Concerns over sourcing reliability have prompted some states to stockpile or experiment with alternatives, yet pentobarbital remains prevalent for its proven lethality in controlled intravenous administration.[](https://indianacapitalchronicle.com/2024/07/05/what-is-pentobarbital-more-questions-than-answers-around-indianas-new-execution-drug/)\n\n## Legal and Regulatory Framework\n\n### Controlled Substance Status\n\nIn the United States, barbiturates are classified as controlled substances under the Controlled Substances Act of 1970, administered by the Drug Enforcement Administration (DEA), with scheduling determined by abuse potential, medical utility, and dependence liability. Short-acting barbiturates such as secobarbital and pentobarbital are placed in Schedule II, reflecting their high potential for abuse alongside accepted uses in anesthesia and acute sedation.[](https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf) [](https://www.dea.gov/factsheets/barbiturates) Intermediate-acting compounds like amobarbital also fall under Schedule II.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) Longer-acting barbiturates, including phenobarbital used for epilepsy management, are scheduled in Schedule IV due to comparatively lower abuse risk.[](https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf) Certain formulations, such as those containing butalbital, are classified in Schedule III.[](https://www.regulations.gov/document/DEA-2022-0027-0001) Schedule II and III status mandates strict prescription requirements, including no refills without new authorization and inventory tracking for manufacturers and pharmacies, while Schedule IV allows limited refills under medical supervision.[](https://www.dea.gov/drug-information/drug-scheduling)\n\nInternationally, barbiturates are regulated under the 1971 United Nations Convention on Psychotropic Substances, which lists twelve specific compounds across its Schedules II, III, and IV based on therapeutic value versus risk of misuse. Schedule II includes high-potency sedatives like secobarbital and amobarbital, requiring stringent import/export controls and medical justifications; Schedule III covers intermediates like pentobarbital; and Schedule IV encompasses milder agents such as phenobarbital, permitting broader medical access with safeguards against diversion.[](https://www.euda.europa.eu/publications/drug-profiles/barbiturates_en) [](https://www.who.int/groups/ecdd/about-us/substance-control-ecosystem) Parties to the convention, numbering over 180 nations as of 2021, must limit production to medical and scientific needs, enforce licensing, and report statistics to the International Narcotics Control Board.[](https://www.incb.org/incb/en/news/news_2021/50-years-of-international-control-in-psychotropic-substances.html)\n\nIn the United Kingdom, barbiturates are designated Class B drugs under the Misuse of Drugs Act 1971, carrying penalties of up to 5 years imprisonment and unlimited fines for unlawful possession or supply, with most placed in Schedule 3 of the Misuse of Drugs Regulations 2001 to restrict non-medical handling.[](https://www.gov.uk/government/publications/controlled-drugs-list--2) [](https://www.drugwise.org.uk/what-are-the-uk-drug-laws/) Prescriptions require safe custody storage and detailed record-keeping, prohibiting private imports without Home Office approval. In Canada, they are controlled under the Controlled Drugs and Substances Act as narcotics or designated substances, necessitating prescriptions and compliance with federal monitoring for cross-border transport.[](https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/controlled-substances/compliance-monitoring/travelling-into-and-out-of-canada-with-prescription-medication-containing-controlled-substances.html) European Union member states align with UN schedules, implementing national variations such as Schedule IV classifications for phenobarbital in several countries, emphasizing veterinary and limited human therapeutic exemptions.[](https://www.euda.europa.eu/publications/drug-profiles/barbiturates_en) These frameworks stem from documented risks of overdose and dependence established in mid-20th-century epidemiological data, prioritizing harm reduction through regulated access over prohibition.[](https://www.unodc.org/pdf/convention_1971_en.pdf)\n\n### Patterns of Non-Medical Use\n\nNon-medical use of barbiturates primarily involves seeking sedative, euphoric, or disinhibiting effects, often to counteract stimulation from other substances or to induce relaxation akin to alcohol intoxication. Such misuse became evident in the 1930s, with users reporting \"drunk-like\" states from oral ingestion, escalating through the mid-20th century as prescriptions proliferated for anxiety and insomnia.[](https://www.sciencedirect.com/topics/medicine-and-dentistry/barbital)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/) By the 1960s and 1970s, recreational patterns intensified, including polydrug combinations with alcohol, opioids, or stimulants like amphetamines to balance highs or enhance sedation, though this amplified overdose lethality due to synergistic respiratory depression.[](https://www.therecoveryvillage.com/barbiturate-addiction/)[](https://www.dea.gov/factsheets/barbiturates)\n\nAbuse methods typically entail oral consumption of diverted prescriptions, with higher-risk patterns featuring intravenous injection in dependent users to achieve rapid onset, though this is less common today owing to availability constraints.[](https://www.news-medical.net/health/Barbiturate-Abuse.aspx) Users, frequently those already addicted to other depressants or stimulants, escalate doses to tolerate tolerance, leading to cycles of bingeing followed by withdrawal-driven compulsion.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2495124/) Historical data from U.S. congressional inquiries in the early 1970s highlighted barbiturates' role in widespread sedative abuse, often among urban populations and polysubstance users, prompting tighter controls.[](https://www.govinfo.gov/content/pkg/CPRT-92SPRT87006/pdf/CPRT-92SPRT87006.pdf)\n\nCurrent patterns reflect sharp decline since the 1970s, driven by prescription reductions, benzodiazepine substitution, and Schedule II/III classifications under the Controlled Substances Act, rendering non-medical access sporadic via illicit diversion or stockpiles. In 2018, an estimated 405,000 Americans aged 12 and older reported past-year misuse, representing under 0.2% of that population, with adolescent involvement minimal at about 2% of 12th graders.[](https://americanaddictioncenters.org/barbiturate)[](https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/what-scope-prescription-drug-misuse) Lifetime exposure to abuse affects roughly 9% of Americans, but active patterns cluster among older adults with legacy prescriptions or those in opioid recovery substituting for withdrawal symptoms.[](https://www.lakeviewbehavioralhealth.com/addiction/barbiturates/effects-signs-symptoms/) Drug testing data confirm rarity, with barbiturate positives comprising only 1.1% of abuse panels over extended periods.[](https://www.healthcare.uiowa.edu/path_handbook/lab_bulletins/archived/2010/DrugOfAbuseUpdate.html) Despite low prevalence, residual risks persist in polysubstance contexts, underscoring barbiturates' niche but hazardous non-medical niche.[](https://drugabuse.com/drugs/barbiturates/)\n\n## Specific Compounds and Examples\n\n![Barbiturates generic structures](./_assets_/Barbiturates_generic_numbered.svg.png)\n\nBarbiturates are classified by duration of action, influencing their clinical applications: ultra-short-acting for induction of anesthesia, short- to intermediate-acting for hypnosis and sedation, and long-acting for seizure control.[](https://my.clevelandclinic.org/health/treatments/23271-barbiturates)[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)\n\nPhenobarbital, a long-acting barbiturate with a half-life of 37 to 140 hours, is primarily used as an anticonvulsant for epilepsy and febrile seizures in children, and occasionally for preoperative sedation or alcohol withdrawal management.[](https://www.drugs.com/drug-class/barbiturates.html)[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) Secobarbital, a short-acting compound with effects lasting 15 to 50 hours in terms of elimination half-life, was historically prescribed as a hypnotic for short-term insomnia treatment but is now rarely used due to risks of dependence.[](https://www.drugs.com/drug-class/barbiturates.html)[](https://my.clevelandclinic.org/health/treatments/23271-barbiturates)\n\nPentobarbital, another short- to intermediate-acting barbiturate, serves as a sedative-hypnotic for preoperative anxiety, seizure control in emergencies, and has been employed in euthanasia protocols and capital punishment in some jurisdictions.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)[](https://www.dea.gov/factsheets/barbiturates) Thiopental, an ultra-short-acting intravenous agent, is utilized for rapid induction of general anesthesia, providing unconsciousness within seconds, though its use has declined with safer alternatives.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)[](https://my.clevelandclinic.org/health/treatments/23271-barbiturates)\n\nButalbital, an intermediate-acting barbiturate, is combined with caffeine and analgesics in formulations like Fioricet for tension headaches, despite limited evidence of superior efficacy over non-barbiturate options and potential for misuse.[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)[](https://www.dea.gov/factsheets/barbiturates) Primidone, a barbiturate derivative, functions as an anticonvulsant for essential tremors and epilepsy, metabolized partly to phenobarbital, with a shorter half-life of 5 to 15 hours.[](https://www.drugs.com/drug-class/barbiturates.html)[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)\n\n| Compound | Duration of Action | Primary Uses |\n|----------|---------------------|--------------|\n| Phenobarbital | Long-acting | Anticonvulsant for epilepsy[](https://www.drugs.com/drug-class/barbiturates.html) |\n| Secobarbital | Short-acting | Hypnotic for insomnia (historical)[](https://my.clevelandclinic.org/health/treatments/23271-barbiturates) |\n| Pentobarbital | Short- to intermediate-acting | Sedation, seizures, euthanasia[](https://www.dea.gov/factsheets/barbiturates) |\n| Thiopental | Ultra-short-acting | Anesthesia induction[](https://www.ncbi.nlm.nih.gov/books/NBK539731/) |\n| Butalbital | Intermediate-acting | Headache relief in combinations[](https://www.ncbi.nlm.nih.gov/books/NBK539731/)"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761886827465,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"Barbiturates - StatPearls - NCBI Bookshelf - NIH\",\"description\":\"Barbiturates are a category of sedative-hypnotic medications used for treating seizure disorders, neonatal withdrawal, insomnia, preoperative anxiety,Â ...Indications Â· Administration Â· Contraindications Â· Monitoring\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK539731/\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"The history of barbiturates a century after their clinical introduction\",\"description\":\"Barbiturates were also useful in the treatment of sleep disorders as well as being the first truly effective pharmacological tools for the management ofÂ ...Missing:  definition | Show results with:definition\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2424120/\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"One hundred years of barbiturates and their saint - PMC\",\"description\":\"Phenobarbitone is considered a sedative rather than a hypnotic substance and according to the Controlled Substances Act grouping it has low abuse potential. InÂ ...Missing:  definition risks\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC1079678/\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"Barbiturates - PubMed\",\"description\":\"Barbiturates are dangerous drugs, with a narrow therapeutic index between the dose required for sedation and the dose that will cause coma and death.Missing:  definition risks\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/9255991/\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"Barbiturate Toxicity - StatPearls - NCBI Bookshelf - NIH\",\"description\":\"Feb 28, 2024 Â· Barbiturates are sedative-hypnotic drugs. They are derivates of barbituric acid and were introduced clinically in the early 1900s.\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK499875/\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"Barbituric Acid | C4H4N2O3 | CID 6211 - PubChem - NIH\",\"description\":\"Barbituric acid is a barbiturate, the structure of which is that of perhydropyrimidine substituted at C-2, -4 and -6 by oxo groups.\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/Barbituric-Acid\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"Barbituric Acid - an overview | ScienceDirect Topics\",\"description\":\"The parent compound in this class is barbituric acid (2,4,6(1H,3H,5H)-pyrimidinetrione). In contrast to its 5-substituted derivatives, it has no hypnoticÂ ...\",\"url\":\"https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/barbituric-acid\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"Barbiturates | Synthesis and Drug Profile | Sedatives and Hypnotics\",\"description\":\"Barbiturates are derivatives of barbituric acid. Their hypnotic activity is conferred by the replacement of H-atom attached to the C-5 position by aryl or alkylÂ ...\",\"url\":\"https://www.pharmacy180.com/article/barbiturates-2101/\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"Barbiturates drug profile | www.euda.europa.eu - European Union\",\"description\":\"Barbiturates act by enhancing the action of GABA through binding to a site on the GABAA receptor/chloride channel, a property they share with benzodiazepines;Â ...\",\"url\":\"https://www.euda.europa.eu/publications/drug-profiles/barbiturates_en\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"22.8: Chemistry Mattersâ€”Barbiturates\",\"description\":\"Sep 30, 2024 Â· 2 : The synthesis of barbiturates relies on malonic ester alkylations and nucleophilic acyl substitution reactions. More than 2500 differentÂ ...\",\"url\":\"https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_%28OpenStax%29/22%253A_Carbonyl_Alpha-Substitution_Reactions/22.08%253A_Chemistry_MattersBarbiturates\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"Barbiturates and Benzodiazepines - Chemistry LibreTexts\",\"description\":\"Jul 4, 2022 Â· The structures of the barbiturates can be related to the duration of effective action. Although over 2000 derivatives of barbituric acid haveÂ ...\u003c|separator|\u003e\",\"url\":\"https://chem.libretexts.org/Bookshelves/Biological_Chemistry/Supplemental_Modules_%28Biological_Chemistry%29/Pharmaceuticals/Barbiturates_and_Benzodiazepines\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"Barbiturates | Anesthesiology Core Review: Part One Basic Exam\",\"description\":\"Barbiturates are derivatives of barbituric acid. The presence of oxygen in the pyrimidine nucleus at carbon 2 position makes the drug an oxybarbiturate (eg,Â ...\",\"url\":\"https://accessanesthesiology.mhmedical.com/content.aspx?sectionid=61587846\u0026bookid=974\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"Barbiturates | Tintinalli's Emergency Medicine\",\"description\":\"Barbiturates are generally classified according to their duration of action, which is primarily dependent on lipid solubility and tissue distribution ratherÂ ...\",\"url\":\"https://accessemergencymedicine.mhmedical.com/content.aspx?bookid=2353\u0026sectionid=220744425\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"Barbiturates: Definition, Types, Uses, Side Effects \u0026 Abuse\",\"description\":\"Jun 14, 2022 Â· Barbiturates are medications that cause you to relax or feel drowsy. They can also stop or prevent convulsions and seizures.Overview Â· What Are Barbiturates? Â· Risks / Benefits\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://my.clevelandclinic.org/health/treatments/23271-barbiturates\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"Barbiturate - an overview | ScienceDirect Topics\",\"description\":\"Long-acting: barbiturates act within 2 h. The duration of action lasts for 6â€“12 h (eg, barbitone, phenobarbital, mephobarbitone, methyl phenobarbital,Â ...\",\"url\":\"https://www.sciencedirect.com/topics/medicine-and-dentistry/barbiturate\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"List of Common Barbiturates + Uses \u0026 Side Effects - Drugs.com\",\"description\":\"Apr 12, 2023 Â· Common Barbiturates available in the U.S. ; pentobarbital Â· Nembutal sodium, 15-50h ; phenobarbital, Generic, 37-140h ; primidone Â· Mysoline, 5-15h.\",\"url\":\"https://www.drugs.com/drug-class/barbiturates.html\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"Barbiturate - an overview | ScienceDirect Topics\",\"description\":\"Other short-acting and intermediate-acting barbiturates include amobarbital (Amytal), pentobarbital (Nembutal), secobarbital (Seconal and Tuinal, an amobarbitalÂ ...\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/barbiturate\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"Barbituric Acid\",\"description\":\"Barbituric acid was first discovered by the German chemist Adolf von Baeyer in 1864 by combining urea (an animal waste product) with malonic acid (derived fromÂ ...\",\"url\":\"https://www.ch.ic.ac.uk/rzepa/mim/drugs/html/barbiturate.htm\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"Adolf von Baeyer (1835 - 1917) - Utopian Surgery?\",\"description\":\"In 1864, von Baeyer synthesised barbituric acid. The word \\\"barbiturate\\\" is a combination of \\\"Barbara\\\" with \\\"urea\\\": von Baeyer discovered the compound on SaintÂ ...\",\"url\":\"https://www.general-anaesthesia.com/people/adolf-baeyer.html\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"Barbiturate History - News-Medical\",\"description\":\"Barbiturates were synthesized in 1864 by Adolf von Baeyer. The process was then perfected by the French chemist Edouard Grimaux in 1879.\",\"url\":\"https://www.news-medical.net/health/Barbiturate-History.aspx\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"The story of barbituric acid - ACS Publications\",\"description\":\"His work led eventually to the discovery of the hypnotic properties of diethylbarbituric acid. It should be noted that in 1882 Max Conradand Max Guthzeit pre-.\",\"url\":\"https://pubs.acs.org/doi/pdf/10.1021/ed028p524\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"Top Pharmaceuticals: Phenobarbital - American Chemical Society\",\"description\":\"Emil Fischer and Joseph von Mering uncovered the medical value of the barbiturates in 1903. Their compound, diethylbarbituric acid, or Veronal, helped dogsÂ ...Missing:  barbital | Show results with:barbital\",\"url\":\"https://pubsapp.acs.org/cen/coverstory/83/8325/8325phenobarbital.html\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"the story of phenobarbital therapy in epilepsy in the last 100 years\",\"description\":\"Phenobarbital (phenobarbitone) was first used as an antiepileptic drug 100 years ago, in 1912. This article tells the story of the discovery of itsÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/23205960/\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"Barbiturate Toxicity: Practice Essentials, Background, Pathophysiology\",\"description\":\"Jan 16, 2025 Â· Barbiturate abuse was popular in the 1960s and 1970s. Since then, its popularity has waned because of stricter guidelines for use and theÂ ...\",\"url\":\"https://emedicine.medscape.com/article/813155-overview\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"Benzodiazepines: What They Are, Uses, Side Effects \u0026 Risks\",\"description\":\"Jan 3, 2023 Â· Before benzodiazepines, doctors primarily prescribed barbiturates for treating anxiety. But these drugs came with significant risks of sideÂ ...\",\"url\":\"https://my.clevelandclinic.org/health/treatments/24570-benzodiazepines-benzos\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"Dihydroquinidine barbiturate: Uses, Interactions, Mechanism of Action\",\"description\":\"Jun 30, 2007 Â· Barbiturates work by binding to the GABAA receptor at either the alpha or the beta sub unit. These are binding sites that are distinct from GABA itself.\",\"url\":\"https://go.drugbank.com/drugs/DB01341\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"How theories evolved concerning the mechanism of action of ...\",\"description\":\"It has long been recognized that barbiturates act by prolonging and potentiating the action of Î³-aminobutyric acid (GABA) on GABA(A) receptors.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/23205959/\",\"favicon\":\"\"},{\"id\":\"28\",\"title\":\"Direct activation of GABAA receptors by barbiturates in cultured rat ...\",\"description\":\"1. The direct activation of the GABAA receptor by pentobarbitone (PB) and phenobarbitone (PHB) was characterized in cultured rat hippocampal neurons using wholeÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC1161000/\",\"favicon\":\"\"},{\"id\":\"29\",\"title\":\"Barbituratesâ€”Pharmacokinetics and Pharmacodynamics\",\"description\":\"Its short duration of action after moderate doses is due to redistribution from the brain to peripheral tissues.\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0261988121001907\",\"favicon\":\"\"},{\"id\":\"30\",\"title\":\"Phenobarbital: MedlinePlus Drug Information\",\"description\":\"May 15, 2020 Â· Phenobarbital is used to control seizures. Phenobarbital is also used to relieve anxiety. It is also used to prevent withdrawal symptoms in people who areÂ ...\",\"url\":\"https://medlineplus.gov/druginfo/meds/a682007.html\",\"favicon\":\"\"},{\"id\":\"31\",\"title\":\"Phenobarbital - StatPearls - NCBI Bookshelf - NIH\",\"description\":\"Feb 28, 2024 Â· Phenobarbital is a member of the barbiturate drug class that holds versatile therapeutic applications. This drug is effective in anti-seizureÂ ...\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK532277/\",\"favicon\":\"\"},{\"id\":\"32\",\"title\":\"[PDF] SEZABY (phenobarbital sodium) - accessdata.fda.gov\",\"description\":\"INDICATIONS AND USAGE---------------------------. SEZABY is a barbiturate indicated for the treatment of neonatal seizures in term and preterm infants. (1).\",\"url\":\"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215910s000lbl.pdf\",\"favicon\":\"\"},{\"id\":\"33\",\"title\":\"[PDF] Butisol SodiumÂ® (Butabarbital Sodium Tablets, USP and ...\",\"description\":\"Barbiturates should be administered with caution, if at all, to patients who are mentally depressed, have suicidal tendencies, or a history of drug abuse.\",\"url\":\"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/000793s026lbl.pdf\",\"favicon\":\"\"},{\"id\":\"34\",\"title\":\"What are Barbiturates? - News-Medical\",\"description\":\"Today, barbiturates are generally only used to treat extreme and serious cases of insomnia. They are also used to help control seizures in epilepsy, as well asÂ ...\",\"url\":\"https://www.news-medical.net/health/What-are-Barbiturates.aspx\",\"favicon\":\"\"},{\"id\":\"35\",\"title\":\"Phenobarbital Uses, Side Effects \u0026 Warnings - Drugs.com\",\"description\":\"Mar 10, 2025 Â· Phenobarbital is used to treat or prevent seizures. Phenobarbital is also used short-term as a sedative to help you relax.\",\"url\":\"https://www.drugs.com/mtm/phenobarbital.html\",\"favicon\":\"\"},{\"id\":\"36\",\"title\":\"Phenobarbital | Anti-Seizure Medication - Epilepsy Foundation\",\"description\":\"Jun 6, 2024 Â· Phenobarbital is often used as an \\\"add-on\\\" medicine for people who continue to have seizures while taking other seizure medicines. It doesÂ ...Used To Treat Â· Forms Â· Frequently Asked Questions\u003c|separator|\u003e\",\"url\":\"https://www.epilepsy.com/tools-resources/seizure-medication-list/phenobarbital\",\"favicon\":\"\"},{\"id\":\"37\",\"title\":\"Phenobarbital - Veterinary Partner - VIN\",\"description\":\"Phenobarbital is a barbiturate used to suppress seizures in dogs and cats, effective for various causes, and is usually the first choice.\",\"url\":\"https://veterinarypartner.vin.com/doc/?id=4951404\u0026pid=19239\",\"favicon\":\"\"},{\"id\":\"38\",\"title\":\"Phenobarbital for Dogs and Cats - Pet Medications - PetMD\",\"description\":\"Jun 27, 2023 Â· Phenobarbital treats seizures in dogs and cats, and is used for epilepsy, brain tumors, infectious disease, and some toxins. It is used in dogsÂ ...\",\"url\":\"https://www.petmd.com/pet-medication/phenobarbital-dogs-and-cats\",\"favicon\":\"\"},{\"id\":\"39\",\"title\":\"FDA Conditionally Approves Phenobarbital for Seizures in Dogs\",\"description\":\"Sep 6, 2023 Â· The US Food and Drug Administration conditionally approved Fidoquel-CA1 (phenobarbital tablets) for the control of seizures associated with idiopathic epilepsyÂ ...\",\"url\":\"https://www.fda.gov/animal-veterinary/cvm-updates/fda-conditionally-approves-phenobarbital-tablets-control-seizures-dogs-idiopathic-epilepsy\",\"favicon\":\"\"},{\"id\":\"40\",\"title\":\"Once-a-day oral treatment with phenobarbital in cats with ... - NIH\",\"description\":\"Sep 25, 2023 Â· Once-a-day oral phenobarbital resulted in 88% seizure remission and good control in 12% of cats, with no side effects or compliance issues.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10812035/\",\"favicon\":\"\"},{\"id\":\"41\",\"title\":\"Facts About Euthanasia (Small Animals)\",\"description\":\"The euthanasia solution is usually a barbiturate- the same class of drugs used for general anesthesia.\",\"url\":\"https://www.vet.cornell.edu/facts-about-euthanasia-small-animals\",\"favicon\":\"\"},{\"id\":\"42\",\"title\":\"EUTHASOLÂ® (pentobarbital sodium and phenytoin sodium ... - Virbac\",\"description\":\"EUTHASOLÂ® (pentobarbital sodium and phenytoin sodium) Euthanasia Solution for use in dogs for humane, painless and rapid euthanasia.\",\"url\":\"https://vet-us.virbac.com/home/products/in-clinic-use/euthasol-pentobarbital-sodium-an.html\",\"favicon\":\"\"},{\"id\":\"43\",\"title\":\"Barbiturates - USGS Publications Warehouse\",\"description\":\"Barbiturate products are commonly used to euthanize domestic animals. The primary active component in euthanasia solutions is sodium pentobarbital.\",\"url\":\"https://pubs.usgs.gov/publication/2001158\",\"favicon\":\"\"},{\"id\":\"44\",\"title\":\"Help prevent euthanasia drugs from killing bald eagles and other ...\",\"description\":\"When an animal is euthanized by pentobarbital injection, the drug is quickly distributed throughout its body. When a scavenger feeds on the carcass, the degreeÂ ...\",\"url\":\"https://www.fws.gov/story/help-prevent-euthanasia-drugs-killing-bald-eagles-and-other-wildlife\",\"favicon\":\"\"},{\"id\":\"45\",\"title\":\"Pentobarbital back orders and potential alternatives\",\"description\":\"May 18, 2021 Â· Pentobarbital or pentobarbital combination drugs, that are approved by FDA CVM, are a preferred method for euthanasia of dogs, cats, and otherÂ ...\",\"url\":\"https://www.avma.org/blog/pentobarbital-back-orders-and-potential-alternatives\",\"favicon\":\"\"},{\"id\":\"46\",\"title\":\"Humane Euthanasia\",\"description\":\"Dr. Aleman determined that horses rapidly lose all perception of consciousness within 10 seconds of administration of pentobarbital and the brain wave is flat.\u003c|separator|\u003e\",\"url\":\"https://compneuro.vetmed.ucdavis.edu/research/humane-euthanasia\",\"favicon\":\"\"},{\"id\":\"47\",\"title\":\"Thiopental (PentothalÂ®) for Dogs and Cats | PetPlace.com\",\"description\":\"Jul 17, 2015 Â· Thiopental is used to induce anesthesia. It is also used to maintain anesthesia for short, non-painful procedures. Precautions and Side Effects.\",\"url\":\"https://www.petplace.com/article/drug-library/drug-library/library/thiopental-pentothal-for-dogs-and-cats\",\"favicon\":\"\"},{\"id\":\"48\",\"title\":\"Injectable Anesthetic Agents - Veterian Key\",\"description\":\"Feb 8, 2018 Â· The major uses for barbiturates in veterinary medicine are as induction agents for anesthesia, anticonvulsants, and euthanasia agents.\",\"url\":\"https://veteriankey.com/injectable-anesthetic-agents/\",\"favicon\":\"\"},{\"id\":\"49\",\"title\":\"Veterinary Anesthesia Demystified - Wilderness Animal Hospital\",\"description\":\"Dec 21, 2020 Â· Current anesthetics, such as propofol are a much safer and have for the most part replaced the barbiturates previously used for anestheticÂ ...\",\"url\":\"https://wildernessvet.com/veterinary-anesthesia-demystified/\",\"favicon\":\"\"},{\"id\":\"50\",\"title\":\"Cardiovascular and respiratory effects of thiopental administration in ...\",\"description\":\"The cardiopulmonary effects of thiopental sodium were studied in hypovolemic dogs from completion of until 1 hour after administration of the drug.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/2053727/\",\"favicon\":\"\"},{\"id\":\"51\",\"title\":\"[PDF] Pharmacology - Intravenous Anesthetic Agents \u0026 Dissociatives Lyon ...\",\"description\":\"Patients with hyperthyroidism - thiobarbiturates have antithyroid effect. In large animals, ultra-short acting barbiturates are usually used in combinationÂ ...\",\"url\":\"https://www.westernu.edu/mediafiles/veterinary/vet-anesthesia-analgesia/pharmacology-intravenous-anesthetic-agents-dissociatives.pdf\",\"favicon\":\"\"},{\"id\":\"52\",\"title\":\"Barbiturate intoxication and overdose - MedlinePlus\",\"description\":\"Jul 1, 2023 Â· Possible Complications Â· Coma Â· Death Â· Head injury and concussion from falls when intoxicated Â· Miscarriage in pregnant women or damage to theÂ ...\",\"url\":\"https://medlineplus.gov/ency/article/000951.htm\",\"favicon\":\"\"},{\"id\":\"53\",\"title\":\"Barbiturate Overdose | Signs \u0026 Symptoms of Drug ... - DrugAbuse.com\",\"description\":\"Aug 7, 2025 Â· Barbiturate overdose can be dangerous and possibly fatal, with approximately 10% of barbiturate overdoses resulting in death.\u003c|separator|\u003e\",\"url\":\"https://drugabuse.com/drugs/barbiturates/overdose/\",\"favicon\":\"\"},{\"id\":\"54\",\"title\":\"Minireview Pharmacology of barbiturate tolerance/dependence\",\"description\":\"In this minireview, we mainly focus on molecular and cellular aspects of the action of barbiturates and the possible mechanisms that contribute to developmentÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/0024320596001993\",\"favicon\":\"\"},{\"id\":\"55\",\"title\":\"Barbiturate Dependence: Symptoms, Causes, Treatment Options\",\"description\":\"Dec 20, 2024 Â· Long-term use of barbiturates, even at therapeutic doses, results in dependence, according to a study by Suddock JT, Kent KJ, Regina AC, et al.\",\"url\":\"https://addictionresource.com/drugs/barbiturates/dependence/\",\"favicon\":\"\"},{\"id\":\"56\",\"title\":\"[Barbiturate withdrawal syndrome: a case associated with the abuse ...\",\"description\":\"Barbiturates can produce psychological and physical dependence and produce a withdrawal syndrome on the second to fourth day after the drug is suspended.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/10349206/\",\"favicon\":\"\"},{\"id\":\"57\",\"title\":\"correlated differences in withdrawal from other sedative drugs\",\"description\":\"In general, the withdrawal syndrome is characterized acutely by anxiety, nausea, tremor, and convulsions, among other symptoms [21]. Similarities among theÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S0006899304003737\",\"favicon\":\"\"},{\"id\":\"58\",\"title\":\"Alcohol, barbiturate and benzodiazepine withdrawal syndromes - NIH\",\"description\":\"The symptoms and clinical management of alcohol, barbiturate and benzodiazepine withdrawal syndromes are discussed in this article.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC1268024/\",\"favicon\":\"\"},{\"id\":\"59\",\"title\":\"BARBITURATES | Poisoning \u0026 Drug Overdose, 7e | AccessMedicine\",\"description\":\"The potentially fatal oral dose of the shorter-acting agents such as pentobarbital is 2â€“3 g, compared with 6â€“10 g for phenobarbital. Â· Several deaths wereÂ ...Missing:  statistics | Show results with:statistics\",\"url\":\"https://accessmedicine.mhmedical.com/content.aspx?bookid=2284\u0026sectionid=248383642\",\"favicon\":\"\"},{\"id\":\"60\",\"title\":\"Incidence and Lethality of Suicidal Overdoses by Drug Class - NIH\",\"description\":\"Mar 23, 2020 Â· It consistently was highest for opioids (4.5%-9.5%), followed by antidepressants (2.9%-3.6%) and barbiturates (5.8%-12.2%). eTable 4 in theÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7090840/\",\"favicon\":\"\"},{\"id\":\"61\",\"title\":\"Barbiturate Toxicity Treatment \u0026 Management - Medscape Reference\",\"description\":\"Jan 16, 2025 Â· In chronic, heavy users, 1.5-5 days after the last dose the patient may develop seizures, and, between 3 and 7 days after the last dose,Â ...\",\"url\":\"https://emedicine.medscape.com/article/813155-treatment\",\"favicon\":\"\"},{\"id\":\"62\",\"title\":\"Barbiturate (phenobarbital) poisoning - UpToDate\",\"description\":\"Dec 19, 2023 Â· Outline Â· Sedation/coma Â· Respiratory depression Â· Cardiovascular depression Â· Hypothermia Â· Skin bullae (barb blisters) Â· Others.\",\"url\":\"https://www.uptodate.com/contents/barbiturate-phenobarbital-poisoning\",\"favicon\":\"\"},{\"id\":\"63\",\"title\":\"Barbiturate Overdose: Symptoms, Effects, and Risks\",\"description\":\"Mar 24, 2025 Â· Frequent barbiturate users may experience severe withdrawal symptoms within 8 to 15 hours of stopping the drug.\",\"url\":\"https://americanaddictioncenters.org/barbiturate\",\"favicon\":\"\"},{\"id\":\"64\",\"title\":\"Barbiturates vs benzodiazepines: Mechanisms of action and ...\",\"description\":\"The main difference between barbiturates and benzodiazepines is how they interact with the brain's gamma-aminobutyric acid (GABA) system.\",\"url\":\"https://www.ardurecoverycenter.com/barbiturates-vs-benzodiazepines/\",\"favicon\":\"\"},{\"id\":\"65\",\"title\":\"Benzodiazepine Pharmacology and Central Nervous System ...\",\"description\":\"Owing to the low therapeutic index of barbiturates, benzodiazepines (BZDs) became popular in this country and worldwide many decades ago for a wide range ofÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3684331/\",\"favicon\":\"\"},{\"id\":\"66\",\"title\":\"Barbiturates vs. Benzodiazepines | What is the Difference?\",\"description\":\"Safety Profile: Benzodiazepines are considered safer than barbiturates, with a wider margin of safety and a lower risk of fatal overdose.Help Is Available Â· Outpatient Treatment Options Â· Services We Offer\u003c|separator|\u003e\",\"url\":\"https://www.tresvistasrecovery.com/services/outpatient-benzo-detox/barbiturates-vs-benzodiazepines/\",\"favicon\":\"\"},{\"id\":\"67\",\"title\":\"Barbiturates vs. Benzodiazepines: Understanding the Difference\",\"description\":\"Dec 20, 2023 Â· Benzodiazepines have largely replaced barbiturates in medical practice due to their lower risk of addiction. Illegal barbiturates are scarcelyÂ ...\",\"url\":\"https://www.gratitudelodge.com/drug-info/vs/barbiturates-vs-benzodiazepines/\",\"favicon\":\"\"},{\"id\":\"68\",\"title\":\"Comparing Effects: Barbiturates vs. Benzodiazepines\",\"description\":\"Apr 9, 2024 Â· They are less commonly prescribed today due to their narrow therapeutic index, meaning the difference between the effective dose and the lethalÂ ...\",\"url\":\"https://impactoutpatientprogram.com/barbiturates-vs-benzodiazepines-an-in-depth-look-at-their-effects-and-risks/\",\"favicon\":\"\"},{\"id\":\"69\",\"title\":\"Benzodiazepines: Their Use either as Essential Medicines or as ...\",\"description\":\"Feb 1, 2021 Â· BDZs started to be used in 1957 as a safer alternative to the use of barbiturates, which in turn replaced all the opiate derivatives when theyÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7912725/\",\"favicon\":\"\"},{\"id\":\"70\",\"title\":\"Benzodiazepines VS Barbiturates for Anxiety Treatment\",\"description\":\"Benzodiazepines are considered safer than barbiturates, particularly when it comes to the risk of overdose. While both drug classes depress the CNS,Â ...Missing:  index | Show results with:index\",\"url\":\"https://psyclarityhealth.com/benzodiazepines-vs-barbiturates-for-anxiety-treatment/\",\"favicon\":\"\"},{\"id\":\"71\",\"title\":\"The Differences Between Barbiturates vs Benzodiazepines\",\"description\":\"With a greater margin between the effective and lethal dose, benzodiazepines allow for safer dosing. Barbiturates have a much narrower therapeutic indexÂ ...\",\"url\":\"https://arkviewbh.com/rehab-blog/barbiturates-vs-benzodiazepines/\",\"favicon\":\"\"},{\"id\":\"72\",\"title\":\"Barbiturates vs Benzodiazepines: What's The Difference?\",\"description\":\"Jan 22, 2021 Â· Barbiturates have largely been replaced by benzodiazepines due to their high risk of causing addiction or a fatal overdose. TheseÂ ...\",\"url\":\"https://www.thefreedomcenter.com/barbiturates-vs-benzodiazepines/\",\"favicon\":\"\"},{\"id\":\"73\",\"title\":\"Beyond classical benzodiazepines: Novel therapeutic potential of ...\",\"description\":\"As sedative-hypnotic (sleep-inducing) drugs, they have essentially replaced the barbiturates owing to a substantially improved therapeutic index.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3375401/\",\"favicon\":\"\"},{\"id\":\"74\",\"title\":\"Barbiturates - ACNP\",\"description\":\"The barbiturates have sedative-hypnotic, anticonvulsant, anesthetic and respiratory depressant effects that are mediated by their actions at various targetÂ ...\",\"url\":\"http://www.acnp.org/g4/GN401000173/CH169.html\",\"favicon\":\"\"},{\"id\":\"75\",\"title\":\"Barbiturate Toxicity - PubMed\",\"description\":\"Feb 28, 2024 Â· Thus, the use of these drugs has declined mainly in the last several decades in favor of agents with more favorable safety profiles. Despite aÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/29763050/\",\"favicon\":\"\"},{\"id\":\"76\",\"title\":\"What is â€œTruth Serum?â€ | Office for Science and Society\",\"description\":\"Mar 20, 2017 Â· ... Barbiturates, like sodium amytal and sodium pentothal, were used extensively during World War II for psychiatric ... truth-inducing drugs.Missing:  evidence | Show results with:evidence\",\"url\":\"https://www.mcgill.ca/oss/article/drugs-history-you-asked/what-truth-serum\",\"favicon\":\"\"},{\"id\":\"77\",\"title\":\"'Truth Serum' Is a Real Drug Group. How It Works - Business Insider\",\"description\":\"Mar 5, 2023 Â· Truth serum refers to a number of mind-altering drugs that are supposed to make you incapable of lying, but the reality is no drug is powerful enough.\",\"url\":\"https://www.businessinsider.com/is-there-such-a-thing-as-truth-serum-2014-10\",\"favicon\":\"\"},{\"id\":\"78\",\"title\":\"[PDF] \\\"Truth\\\" Drugs in Interrogation - CIA\",\"description\":\"May 8, 2007 Â· If the ethical considerations which in Western countries inhibit the use of narco-interrogation in police work are felt also in intelligence,Â ...\",\"url\":\"https://www.cia.gov/resources/csi/static/Truth-Drugs-in-Interrogation.pdf\",\"favicon\":\"\"},{\"id\":\"79\",\"title\":\"The Chemistry of Truthfulness | On Wisconsin Magazine\",\"description\":\"UW Professor William Bleckwenn 1917, who first used sodium amytal to treat people with schizophrenia, had little idea that his pioneering work would lead toÂ ...\",\"url\":\"https://onwisconsin.uwalumni.com/the-chemistry-of-truthfulness/\",\"favicon\":\"\"},{\"id\":\"80\",\"title\":\"Can a drug make you tell the truth? - BBC News\",\"description\":\"Oct 3, 2013 Â· Michael Mosley undergoes interrogation after taking the \\\"truth drug\\\" sodium thiopental, to see how effective it really is.\",\"url\":\"https://www.bbc.com/news/magazine-24371140\",\"favicon\":\"\"},{\"id\":\"81\",\"title\":\"Stranger Than Fiction - Science History Institute\",\"description\":\"Dec 3, 2015 Â· Driven by panics over Cold War espionage and violent crime, physicians, spies, and cops repeatedly heralded would-be truth serums and mind-Â ...Missing:  MKUltra | Show results with:MKUltra\",\"url\":\"https://www.sciencehistory.org/stories/magazine/stranger-than-fiction/\",\"favicon\":\"\"},{\"id\":\"82\",\"title\":\"[PDF] Narcoanalysis in Law Enforcement - Scholarly Commons\",\"description\":\"(1960), defendant was given a truth serum test before the trial by a psychiatrist employed by him. The court refused to admit testimony of the psychiatrist toÂ ...\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://scholarlycommons.law.northwestern.edu/cgi/viewcontent.cgi?article=5056\u0026context=jclc\",\"favicon\":\"\"},{\"id\":\"83\",\"title\":\"Of ethically compromising positions and blatant lies about 'truth serum'\",\"description\":\"For ethical reasons the psychiatrist is advised against performing narcoanalysis when the examination is requested as an aid to criminal investigationâ€. NothingÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2900002/\",\"favicon\":\"\"},{\"id\":\"84\",\"title\":\"[PDF] Project MKULTRA, THE CIA'S PROGRAM OF RESEARCH IN ...\",\"description\":\"SENATE SELECT COMMITTEE ON INTELLIGENCE. (Established by S. Res. 400, 94th Cong., 2d sess.) DANIEL K. INOUYE, Hawaii, Chairman.\",\"url\":\"https://www.intelligence.senate.gov/wp-content/uploads/2024/08/sites-default-files-hearings-95mkultra.pdf\",\"favicon\":\"\"},{\"id\":\"85\",\"title\":\"Physician-Assisted Suicide: Challenges for Pharmacists - Page 3\",\"description\":\"Currently in Oregon, secobarbital is the medication most commonly prescribed for physician-assisted suicide, followed by pentobarbital.\u003c|separator|\u003e\",\"url\":\"https://www.medscape.com/viewarticle/742070_3\",\"favicon\":\"\"},{\"id\":\"86\",\"title\":\"Characterizing 18 Years of the Death With Dignity Act in Oregon - NIH\",\"description\":\"Apr 6, 2017 Â· How is physician-aided dying being used in Oregon? In this analysis of publicly available data, about two-thirds of patients prescribedÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC5824315/\",\"favicon\":\"\"},{\"id\":\"87\",\"title\":\"Assisted suicide: 10 years of dying at Dignitas - BBC News\",\"description\":\"Oct 21, 2012 Â· Ten years ago a British man with terminal cancer travelled to Switzerland and drank a lethal solution of barbiturates to end his life, with his son andÂ ...\",\"url\":\"https://www.bbc.com/news/health-19989167\",\"favicon\":\"\"},{\"id\":\"88\",\"title\":\"Drugs Used for Euthanasia: A Repeated Population-Based Mortality ...\",\"description\":\"Jul 15, 2018 Â· According to guideline recommendations, barbiturates and neuromuscular relaxants are the recommended drugs for euthanasia.\",\"url\":\"https://www.jpsmjournal.com/article/S0885-3924%2818%2930339-7/fulltext\",\"favicon\":\"\"},{\"id\":\"89\",\"title\":\"Deliberate Self-poisoning with a Lethal Dose of Pentobarbital ... - NIH\",\"description\":\"Pentobarbital (PB) is a euthanasia drug in doses of 2 to 10 grams, causing death within 15â€“30 minutes. We report a case of recovery from lethalÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6314932/\",\"favicon\":\"\"},{\"id\":\"90\",\"title\":\"Lethal Injection Drugs' Efficacy And Availability For Federal Executions\",\"description\":\"Jul 26, 2019 Â· Federal executioners will now use pentobarbital, a single drug used by states including Georgia, Missouri and Texas.\",\"url\":\"https://www.npr.org/2019/07/26/745722219/lethal-injection-drugs-efficacy-and-availability-for-federal-executions\",\"favicon\":\"\"},{\"id\":\"91\",\"title\":\"Why the Justice Department's Plan to Use a Single Drug for Lethal ...\",\"description\":\"Jul 29, 2019 Â· As opposed to prior executions, which used multiple drugs for lethal injection, federal executions will only use one drug: pentobarbital.\",\"url\":\"https://time.com/5636513/pentobarbital-executions-justice-department/\",\"favicon\":\"\"},{\"id\":\"92\",\"title\":\"US government resumes executions using pentobarbital injection\",\"description\":\"Jul 29, 2019 Â· Attorney general William P Barr said he was directing the Federal Bureau of Prisons to adopt the execution protocol using only pentobarbital, aÂ ...\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://www.bmj.com/content/366/bmj.l4918\",\"favicon\":\"\"},{\"id\":\"93\",\"title\":\"Texas secretly purchased execution drugs from local pharmacy, Rite ...\",\"description\":\"Jul 10, 2024 Â· Rite-Away Pharmacy and Medical Supply in suburban San Antonio produced injectable pentobarbital from 2019 through at least late 2023 for Texas to use inÂ ...\",\"url\":\"https://www.npr.org/2024/07/10/g-s1-9016/unmarked-cars-and-secret-orders-how-a-pharmacy-prepared-drugs-for-texas-executions\",\"favicon\":\"\"},{\"id\":\"94\",\"title\":\"Compounding Pharmacies - Death Penalty Information Center\",\"description\":\"South Dakota obtained pentobarbital, an anesthetic used in executions, from a compounding pharmacy for the October 15, 2012 execution of Eric Robert. The sameÂ ...\",\"url\":\"https://deathpenaltyinfo.org/executions/methods-of-execution/lethal-injection/compounding-pharmacies\",\"favicon\":\"\"},{\"id\":\"95\",\"title\":\"What is pentobarbital? More questions than answers surround ...\",\"description\":\"Jul 5, 2024 Â· Little is known about how Indiana acquired pentobarbital, a drug that state officials plan to use to restart executions for the first time in more than aÂ ...\",\"url\":\"https://indianacapitalchronicle.com/2024/07/05/what-is-pentobarbital-more-questions-than-answers-around-indianas-new-execution-drug/\",\"favicon\":\"\"},{\"id\":\"96\",\"title\":\"[PDF] Controlled Substances - Alphabetical Order\",\"description\":\"... Schedule, \\\"CSCN\\\" = Controlled Substance Code Number. Controlled Substances ... Barbiturates not specifically listed. Benzethidine. 9606. Y. Benzphetamine.\",\"url\":\"https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf\",\"favicon\":\"\"},{\"id\":\"97\",\"title\":\"Barbiturates - DEA.gov\",\"description\":\"Depressant drug used to help sleep, relieve anxiety, muscle spasms, and prevent seizures. Prescribed names: FiorinaÂ®, PentothalÂ®, SeconalÂ®, or NembutalÂ®.\",\"url\":\"https://www.dea.gov/factsheets/barbiturates\",\"favicon\":\"\"},{\"id\":\"98\",\"title\":\"Schedules of Controlled Substances: Exempted Prescription Products\",\"description\":\"Apr 12, 2022 Â· Butalbital is classified as an intermediate acting barbiturate. Butalbital is a schedule III controlled substance that falls underÂ ...\",\"url\":\"https://www.regulations.gov/document/DEA-2022-0027-0001\",\"favicon\":\"\"},{\"id\":\"99\",\"title\":\"Drug Scheduling - DEA.gov\",\"description\":\"Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of ScheduleÂ ...\",\"url\":\"https://www.dea.gov/drug-information/drug-scheduling\",\"favicon\":\"\"},{\"id\":\"100\",\"title\":\"Substance control ecosystem - World Health Organization (WHO)\",\"description\":\"The 1971 Convention is designed to control psychoactive drugs such as amphetamine-type stimulants (such as MDMA), barbiturates, benzodiazepines, andÂ ...\",\"url\":\"https://www.who.int/groups/ecdd/about-us/substance-control-ecosystem\",\"favicon\":\"\"},{\"id\":\"101\",\"title\":\"50 Years of International Control in Psychotropic Substances - INCB\",\"description\":\"Feb 19, 2021 Â· The 1971 Convention extended-for the first time in history-international regulation of manufacture and trade to psychotropic substances.\",\"url\":\"https://www.incb.org/incb/en/news/news_2021/50-years-of-international-control-in-psychotropic-substances.html\",\"favicon\":\"\"},{\"id\":\"102\",\"title\":\"Controlled drugs list - GOV.UK\",\"description\":\"May 26, 2016 Â· The list shows each drug's respective classifications under both the Misuse of Drugs Act 1971 and the Misuse of Drugs Regulations 2001.List of most commonly Â· Controlled drugs Â· Controlled drugs regulations\",\"url\":\"https://www.gov.uk/government/publications/controlled-drugs-list--2\",\"favicon\":\"\"},{\"id\":\"103\",\"title\":\"What are the UK drug laws? - DrugWise\",\"description\":\"Schedule 3 drugs include barbiturates, flunitrazepam (Rohypnol) and temazepam tranquillisers and are subject to restrictions on prescription writing. (*NoteÂ ...\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://www.drugwise.org.uk/what-are-the-uk-drug-laws/\",\"favicon\":\"\"},{\"id\":\"104\",\"title\":\"Travelling into and out of Canada with prescription medications that ...\",\"description\":\"Mar 2, 2023 Â· If you want to travel to Canada with a medication that contains a narcotic or controlled drug, you must meet certain terms and conditions.\",\"url\":\"https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/controlled-substances/compliance-monitoring/travelling-into-and-out-of-canada-with-prescription-medication-containing-controlled-substances.html\",\"favicon\":\"\"},{\"id\":\"105\",\"title\":\"[PDF] CONVENTION ON PSYCHOTROPIC SUBSTANCES, 1971 - unodc\",\"description\":\"1. If a Party or the World Health Organization has information relating to a substance not yet under international control which in its opinion may require theÂ ...\",\"url\":\"https://www.unodc.org/pdf/convention_1971_en.pdf\",\"favicon\":\"\"},{\"id\":\"106\",\"title\":\"Barbital - an overview | ScienceDirect Topics\",\"description\":\"As safer sedative-hypnotics for those with insomnia or other sleep disturbances were created, use of barbiturates declined quickly; they are rarely used forÂ ...\",\"url\":\"https://www.sciencedirect.com/topics/medicine-and-dentistry/barbital\",\"favicon\":\"\"},{\"id\":\"107\",\"title\":\"Barbiturate Abuse \u0026 Addiction - The Recovery Village\",\"description\":\"Oct 8, 2020 Â· They became popular in the 1960s and 1970s as the go-to treatment option for anxiety, insomnia and seizure disorders. From there, they becameÂ ...\u003c|separator|\u003e\",\"url\":\"https://www.therecoveryvillage.com/barbiturate-addiction/\",\"favicon\":\"\"},{\"id\":\"108\",\"title\":\"Barbiturate Abuse - News-Medical\",\"description\":\"Dependence or physical dependence is defined as a condition when long term use of a drug results in the phenomenon of tolerance and discontinuation or doseÂ ...\",\"url\":\"https://www.news-medical.net/health/Barbiturate-Abuse.aspx\",\"favicon\":\"\"},{\"id\":\"109\",\"title\":\"Barbiturate abuse - PMC - NIH\",\"description\":\"Sadly, some addicts add barbiturates to their abuse of other drugs upon which they depend. Dr d'Orban concludes his survey by telling how those addicted toÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2495124/\",\"favicon\":\"\"},{\"id\":\"110\",\"title\":\"[PDF] BARBITURATE ABUSE IN UNITED STATES THE REPORT OF THE ...\",\"description\":\"Dec 4, 1972 Â· This report is the result of an intensive investigation of barbiturate abuse conducted by the Subcommittee during the past year and a half.\",\"url\":\"https://www.govinfo.gov/content/pkg/CPRT-92SPRT87006/pdf/CPRT-92SPRT87006.pdf\",\"favicon\":\"\"},{\"id\":\"111\",\"title\":\"What is the scope of prescription drug misuse in the United States?\",\"description\":\"An estimated 2% of 12th graders reported misusing sedatives (barbiturates) in the past 12 months. An estimated 1.4% of 8th graders, 1.5% of 10th graders, andÂ ...\",\"url\":\"https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/what-scope-prescription-drug-misuse\",\"favicon\":\"\"},{\"id\":\"112\",\"title\":\"Barbiturates Addiction Symptoms, Side Effects, Signs \u0026 Withdrawal\",\"description\":\"Barbiturate addiction statistics. While not as common today, barbiturate abuse is still a problem for many. Approximately 9% of Americans will abuseÂ ...\",\"url\":\"https://www.lakeviewbehavioralhealth.com/addiction/barbiturates/effects-signs-symptoms/\",\"favicon\":\"\"},{\"id\":\"113\",\"title\":\"Removal of Barbiturates Assay from Routine Drug of Abuse Panels\",\"description\":\"An analysis of drug of abuse test results over the last 7 years has revealed a declining rate of positives for the barbiturates assay, with only 1.1% of drug ofÂ ...\",\"url\":\"https://www.healthcare.uiowa.edu/path_handbook/lab_bulletins/archived/2010/DrugOfAbuseUpdate.html\",\"favicon\":\"\"},{\"id\":\"114\",\"title\":\"Barbiturate Abuse Side Effects, Symptoms, and Addiction Treatment\",\"description\":\"Aug 6, 2025 Â· Abusing barbiturates is extremely dangerous and can lead to severe short- and long-term physical and psychological symptoms, physical dependence, andÂ ...Missing:  rates | Show results with:rates\",\"url\":\"https://drugabuse.com/drugs/barbiturates/\",\"favicon\":\"\"}],\"images\":[{\"id\":\"bdc9cddf1804\",\"caption\":\"Barbituric acid structure\",\"url\":\"./_assets_/Barbituric-acid-structural.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"bdc9cddf1804\",\"caption\":\"Barbituric acid structure\",\"url\":\"./_assets_/Barbituric-acid-structural.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"bdc9cddf1804\",\"caption\":\"Structure of barbituric acid\",\"url\":\"./_assets_/Barbituric-acid-structural.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"2e1e7f64a37f\",\"caption\":\"Barbiturates generic structures\",\"url\":\"./_assets_/Barbiturates_generic_numbered.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0}],\"fixedIssues\":[],\"slug\":\"Barbiturate\",\"title\":\"Barbiturate\",\"content\":\"$1f\",\"description\":\"Barbiturate\\n\\nBarbituric acid structure\\n\\nBarbiturates are a class of sedative-hypnotic drugs derived from barbituric acid, which act as central nervous system depressants by enhancing the inhibitory...\",\"metadata\":{\"categories\":[\"barbs\"],\"lastModified\":\"1761583867\",\"contentLength\":\"65253\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"1159714\",\"recentViews\":\"1159714\",\"dailyAvgViews\":38657.1328125,\"qualityScore\":1,\"lastViewed\":\"1761886827\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761886827460,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"Barbiturate\"],\"queryHash\":\"[\\\"page\\\",\\\"Barbiturate\\\"]\"}]},\"children\":\"$L20\"}]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Barbiturate\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"Barbiturates are a class of sedative-hypnotic drugs derived from barbituric acid, which act as central nervous system depressants by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at GABA_A receptors, leading to sedation, hypnosis, and anticonvulsant properties. First synthesized in 1864 by Adolf von Baeyer, though barbituric acid itself lacks pharmacological activity, the class gained clinical prominence in the early 1900s with the introduction of barbital, revolutionizing...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"keywords\",\"content\":\"barbs\"}],[\"$\",\"meta\",\"5\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"6\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"7\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/Barbiturate\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:title\",\"content\":\"Barbiturate\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:description\",\"content\":\"Barbiturates are a class of sedative-hypnotic drugs derived from barbituric acid, which act as central nervous system depressants by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at GABA_A receptors, leading to sedation, hypnosis, and anticonvulsant properties. First synthesized in 1864 by Adolf von Baeyer, though barbituric acid itself lacks pharmacological activity, the class gained clinical prominence in the early 1900s with the introduction of barbital, revolutionizing...\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/Barbiturate\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:image:alt\",\"content\":\"Barbiturate\"}],[\"$\",\"meta\",\"17\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"18\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:43.867Z\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:title\",\"content\":\"Barbiturate\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:description\",\"content\":\"Barbiturates are a class of sedative-hypnotic drugs derived from barbituric acid, which act as central nervous system depressants by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at GABA_A receptors, leading to sedation, hypnosis, and anticonvulsant properties. First synthesized in 1864 by Adolf von Baeyer, though barbituric acid itself lacks pharmacological activity, the class gained clinical prominence in the early 1900s with the introduction of barbital, revolutionizing...\"}],[\"$\",\"meta\",\"23\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"24\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L21\",\"25\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"22:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"23:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="NDliY2E0ZjctNGEzYi00MzU3LTgwMWUtNTljYzVkOGNjYTFm">self.__next_f.push([1,"20:[\"$\",\"$L22\",null,{\"children\":[\"$\",\"$L23\",null,{\"slug\":\"Barbiturate\"}]}]\n"])</script></body></html>